Bibliography

BIBLIOGRAPHY

1. Selye HA. Syndrome produced by diverse nocuous agents. Nature 1936 ; 38: 32-35.

2. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders, Annals of the New York Academy of Sciences 2004, 1032:1-7.

3. http://www.stress.org/

4. Tinbergen N. Etiology and Stress Diseases Science July 1974: Vol. 185 no. 4145: 20-27.

5. Negrao AB, Deuster PA, Gold PW, Singh A, Chrousos GP: Individual reactivity and physiology of the stress response. Biomedicine and Pharmacotherapy 2000; 54:122-128.

6. Cannon W: The emergency function of the adrenal medulla in pain and the major emotions. American Journal of Physiology 1914; 33: 356-372.

7. Cannon WB: Bodily changes in pain, hunger, fear, and rage; an account of recent researchers into the function of emotional excitement. Appleton and Company, New York, London, 1915

8. McCarty R., Gold P: Catecholamines, Stress, and Disease: A Psychobiological Perspective. Psychosomatic Medicine 1996; 58: 590- 597.

9. J.L. McGaugh, The amygdala modulates the consolidation of memories of emotionally arousing experiences, Annual Review of Neuroscience.2004,27: 1-28

10. O'Connor TM, O'Hallman DJ, Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. Quarterly journal of medicine 2000; 93: 323-33.

11. De Kloet ER., Joe'ls M., Holsboer F. Stress and the brain: from adaptation to disease, Nature Reviews

Neuroscience 2005,6: 463^175.

12. De Kloet ER, Vreugdenhil E., Oitzl M., Joe'ls M. Brain corticosteroid receptor balance in health and disease, Endocrine. Reviews 1998, 19: 269-301.

13 Bale TL., Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors, Annual. .Review of Pharmacology and Toxicology 2004,.44 .525-557.

14. EngelmannM., Ludwig M. The activity of the hypothalamoneurohypophysial system in response to acute stressor exposure:neuroendocrine and electrophysiological observations, Stress 2004, 7: 91-96.

15. Landgraf R. Neuropeptides in anxiety modulation, Handbook of. Experimental .Pharmacology 2005, 335— 369.

16. Sabban EL., Kvetnansky R. Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends in Neurosciences 2001, 24 : 91-98.

17. Fehm HL, Kern W, PetersA. The selfish brain: competition for energy resources. Progress in brain research 2006,153: 129-140.

18. Schmaling KB, Fiedelak JI , Katon WJ, Bader JO, Buchwald DS Prospective study of the prognosis of unexplained chronic fatigue in a clinic-basedcohort. Psychosomatic Medicine 2003,65:1047-54.

19. Khong E., Sim MG, Hulse G. Benzodiazepine dependence. Australian Family Physician 2004, Nov;33(l 1): 923-6.

310

Bibliography

20. Aswal, BS. Screening of Indian medical plants for biological activity. Indian. Journal of Experimental. Biology 1996,34:444-467.

21. Dahanukar S. and Thatte U. Ayurveda Revisited, 3rd edn .Popular Prakashan, Mumbai,2000..

22. Chopra A, Doiphode V. Ayurvedic medicine: core concept, therapeutic principles and current relevance. Medical Clinics of North America 2002; 86:75-89.

23. Dahanukar, SA, Kulkarni, RA. and Rege, NN. Pharmacology of Medicinal Plants and Natural Products, Indian Journal of. Pharmacology 2000, 32 , S81-S118.

24. Sharma, P. (1983) Chikitsasthana. In, Charaka Samhita,Chapter 6; Stanzas 7,8, p3-4, Chaukhambha Orientalia,Varanasi;

25. Ghanekar, BG. (1981). Sutrasthana. In, Sushrut Samhita,Chapter 1; Stanza 7, p.3, Motilal Banarasidas, Varanasi.

26. Rege N., Thatte U. and Dahanukar S., Adaptogenic property of six rasayana herbs used in Ayurvedic medicine. Phytotherapy Research 1999,13,275

27. Lazarev, NV., VII Vsesojuzniy s' ezd /iziologov, biokhimikov ifarmakologov (7th All-union congress of physiology., biochemistry., pharmacology .579, Medgiz, Moscow, ( 1947)

28. Rozin, MA. Lekarstvennie sredstva dlja vosstanovitelnoy terapii i profilaktiki zabolevaniy nervnoi sistemy (Medicinal remedies for restoration therapy and prophyl axis of diseases of the nervous system), Izdanie Voenno-morskoy Medicinskoy Acad., Leningrad, 1951, p 51.

29. Anosov NN., Rozin MA. Pro!l erin, curin, dibazol i ikh primeneniev nevropatologii Prozerin, ezerin, dibazol and their use in neuropathology) Medgiz, Leningrad, 1956,196 .

30. Lazarev KV.,Farmacol. Toxieol, 1958,21, 3, 81-86

31. Lazarev NV., Ljublina EL, Rozin MA., Patol. Fiziol. Eksperim. Terapia, 1959 ,3,4,16- 21.

32. Panossian A., Wikman G., Wagner H., Plant Adaptogens III, Earlier and More Recent Aspects and Concepts On Their Mode of Action. Phytomedicine 1999, 6(4):287-299

33. Brekhman II., and Dardymov IV. New substances of plant origin which increase non-specific resistance. Annual Review of Pharmacology 1969, 9:419-430.

34. Wagner H., Norr H., and Winterhoff H. Plant adaptogens. Phytomedicine 1994, 1: 63-76.

35. Heu, L. Effects of ginseng described in oriental material medica. In, Introduction of Korean Ginseng Elixir of Life, Korean Ginseng and Tobacco Research Institute, Seoul, Korea. ,1983.

36. Singh, N., Nath, R., Lata, A. et al. Withania somnifera (Ashwagandha),a rejuvenating herbal drug which enhances survival during stress (an adaptogen). Inte national Journal of Crude Drug Research 1982,20: 29-35.

37. Bhattacharya SK., Goel RK., Kaur R., and Ghosal SAntistress activity of sitoindosides VII and VIII,new acylsteryglucosides from Withania somnifera. Phytotherapy. Research 1987,1: 32-37.

38. Ghosal, S., Lai, J., Srivastava, R. et al. Immunomodulatory and CNS effects of sitoindosides DC and V, two new glycowithanolides from Withania somnifera. Phytotherapy. Research 1989, 3: 201-206.

39. Bhargava, KP. and Singh, N. Anti-stress activity of Ocimum sanctum Linn. Indian Journal of Medical. Research 1981, 73: 443-451

311

Bibliography

40. Singh, N., Verma, P., Mishra, N., and Nath, R.. A comparative evaluation of some antistress agents of plant

origin. Indian Journal of Pharmacology 1991a, 23: 99-103.

41. Sen, P. Therapeutic potentials of Tulsi: From experiences to facts, Drugs: News and Views 1993,1: 15-20.

42. Ghosal, S., Jaiswal, DD., Singh, SK. et al. Dichotosin and dichotosinin, 2 adaptogenic glucosyloxy rasayans fromHoppea dichotoma. Phytochemistry 1985,24 :831-833.

43. Essman, EJ. The medical uses of herbs. Fitoterapia 1984,55: 279-289.

44. Ushijima, M., Sumioka, I., Kakimoto, M. et al. Effect of garlic and garlic preparations on physiological and psychological stress in mice. Phytotherapy. Research 1997, 11: 226-230.

45. Patil M., Patki P., Kamath HV., and Patwardhan B. Antistress activity of Tinospora cordifolia (Willd) Miers. Indian Drugs 1997, 34: 211-215.

46. Katiyar CK., Brindavanam NB., Tiwari P. and Narayana, DBA.. Immunomodulator products from Ayurveda:Current status and future perspectives. In, Immunomodulation,ed. by S. Upadhyay, Narosa Publishing House, New Delhi. 1997,. 163-187,

47. Davydov M., Krikorian AD. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.(Araliaceae) as an adaptogen: a closer look Journal of Ethnopharmacology 2000,72: 345-393.

48. Schlesinger, MJ., Santoro, MG., and Garaci, E. (eds.): Stress Proteins - Induction and Function. Springer-Verlag, Berlin,14-27.

49. Solomon, GF., and Amkraut, AA. Psychoneuroendocrinologicaleffects on the immune response. Annual Reviews of Microbiology 1981, 35: 155-184.

50. Dantzer, R., and Kelley, KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sciences 1989,44: 1995-2008.

51. McCubbin, JA., Kaufmann, PG., and Nemeroff, CB. In, Stress, Neuropeptides, and Systemic Disease, Academic Press, San Diego, New York. 1991.

52. Thomas Samuel, MathewBaby P., Sakaria, Medicinal plants, Kerala Agricultural Unmiversity,Aromatic and Medicinal plant research center, 1998, 87-88.

53. CharmandariE., TsigosC, Chrousos G., Endocrinology of the stress response, Annual. Review of Physiology 2005, 67:259-284.

54. Chrousos GP., Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture, Annals of New York Academy of Science 851 ,1998, 311-335.

55. Tilbrook AJ, Turner Al., Clarke IJ. Effects of stress on reproduction in non-rodent mammals: considerations of the role of glucocorticoids and sex differences, Reviews of Reproduction. 2000 , 5: 105-113.

56. Tilbrook AJ., A.I. TurnerAL, Clarke IJ. Stress and reproduction central mechanisms and sex differences in non-rodent species, Stress , 2002, 5: 83-100.

57. TurnerAL, CannyBJ., Hobbs RJ., Bond JD., Clarke IJ, Tilbrook AJ. Influence of sex and gonadal status of sheep on Cortisol secretion in response to ACTH and on Cortisol and LH secretion in response to stress: importance of different stressors, Journal of. Endocrinology 2002, 173 : 113-122.

58. TurnerAI , Hemsworth PH. Tilbrook AJ. Susceptibility of reproduction in female pigs to impairment by stress or elevation of Cortisol, Domestic. Animal. Endocrinology 2005,29: 398-410.

312

Bibliography

59. Selye Jans .Stress and GAS. British medical journal 1950,4667

60. Tortora GJ., Grabowoski SR., "The endocrine system" in Principles of Anatomy and Physiology, Published by John willey and sons^O* edition ,2003,620-623

61. Chrousos, GP.; Loriaux, LD.; Gold, PW. The concept ofstress and its historical development. In: Chrousos, G. P.; Loriaux, L. D.; Gold, P. W., eds. Mechanisms of physical and emotional stress. Advances in experimental medicine and biology. 1988, vol. 245, 3-7. *

62. Adams, F. The genuine works of Hippocrates. Baltimore: Williamsand Wilkins Company; 1939, 6

63. Chrousos, GP.; Loriaux, LD.; Gold, PW. The concept ofstress and its historical development. In: Chrousos, GP.; Loriaux, LD.; Gold, PW., eds. Mechanisms of physical and emotional stress. Advances in experimental medicine and biology. 1988, vol. 24, 53-7. 64. Bernard, C. Les phenomenes de la vie. Vol. 1. Paris: Librairie J-BBailliere et Fils; 1878: 879.

65. Bonus, B.; De Kloet, E.; Veldhuis, H. Adrenal steroids and behavioural adaptation: Relationships to brain corticoid receptors. In:Ganten, R.; Pfaff, D., eds. Progress in Neuroendocrinology. Vol 2. Berlin: Springer-Verlag; 1983,1.

66. Selye, H. A syndrome produced by diverse nocuous agents. Nature 1936, 138:32.

67. Selye, H. The general adaptation syndrome and the diseases of adaptation. Journal of Clinical Endocrinology. 1946,6:117-173.

68. Selye, H. The evolution of the stress concept. American Scientist. 1973 ,61:692-699.

69. Harris, GW. Neural control of the pituitary gland. Physiological Reviews.1948,28:134-179.

70. Saffran, M.; Schally, AV.; Bentey, BG. Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophyseal factor. Endocrinology 1955, 57:439-.44.

71.Vale, W.; Spiess, J.; Rivier, C; Rivier, J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and 13-endorphin. Science 1981, 213:1394-1397.

72.Chrousos GP.; Loriaux LD.; Gold PW. The concept ofstress and its historical development. In: Chrousos, G. P.; Loriaux,L. D.; Gold, P. W., eds. Mechanisms of physical and emotional stress,. Advances in experimental medicine and biology .New York: Plenum Press; 1988 , vol. 245: 3-7.

73. Bloom RE.; Battenberg, ELF.; Rivier. J.; Vale, W. Corticotropin releasing factor (CRF): Immunoreactive neurones and fibers in rat hypothalamus, Regulatory. Peptides 1982,4: 43-48.

74. Olschowka JA.; O'Donohue TL.;Mueller GP.; Jacobowitz DM. The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain. Peptides 1982, 3:995-1015.

75. Valentino RJ. CRH effects on central noradrenergic neurons. Relationship to stress. In: Chrousos, G. P.; Loriaux, D. L.; Gold,P. W., eds. Mechanisms of physical and emotional stress. Advancesin experimental medicine and biology, vol. 245. New York: Plenum Press; 1988:47-64.

76. Besedovsky, JO.; del Rey, AE, Sorkin, E. Neuroendocrine immunoregulation. In: Fabris, W.; Garaci, E.; Hadden, J., eds.Immunoregulation. London: Plenum Press; 1983.

77. Rivier, C; Vale, W. Modulation of stress-induced ACTH release by CRF, catecholamines, and vasopressin. Nature 1983, 305:325-327.

313

Bibliography

78. Chrousos, GP.; Loriaux, LD.; Gold, PW. The concept of stress and its historical development. In: Chrousos, GP.; LoriauxJJD.; Gold, PW., eds. Mechanisms of physical and emotional stress, vol. 245. Advances in experimental medicine and biology. New York: Plenum Press; 1988:3-7.

79. Selye H, The evolution of the stress, American, Scientist 1973, 61: 692-695.

80. Armario, Antonio. The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell us About Stressors? CNS & Neurological Disorders. Drug Targets, 2006,5: 485-501.

81. Tilders, FJH.; Berkenbosch, F. CRF and catecholamines; Their place in the central and peripheral regulation of the stress response. Acta Endocrinology. (Suppl. 1 (Copenh.). 1986 ,276: 63-75.

82. Gold PW.; Goodwin FTC.; Chrousos GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress, (first of two parts). The New. England. Journal of. Medicine.19%8, 319: 348-353.

83. Gold PW; Goodwin FK; Chrousos GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress, (second of two parts) TheNew. England. Journal of Medicine. 1988 , 319: 413-420.

84. Scrogin K HPA axis And Stress. Systems Biology October 2007 ,1-12

85. Bloom, RE.; Battenberg, ELF.; Rivier. J.; Vale, W. Corticotropinreleasing factor (CRFI: Immunoreactive neurones and fibersin rat hypothalamus, Regulatory. Peptides 1982,4:43-48.

86. Olschowka JA.; O'Donohue TL.; Mueller GP.; Jacobowitz DM. The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain. Peptides 1982, 3:995-1015.

87. Valentino RJ.; Cha CI.; Foote SL. Anatomic and physiologic evidence for innervation of noradrenergic locus coeruleus by neuronal corticotropin-releasing factor. Society for Neuroscience Abstract. 1986,12:1003.

88. De Souza EB.; lnsel TR.; Perrin MH.; Rivier J.; Vale WW.; Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autoradiographic study. Journal of Neuroscience 1985, 5:3189-3203.

89. Suda, T.; Tomori, N.; Tozawa, F.; Demura, H.; Shizume, K.;Mouri, T.; Miura, Y.; Sasaro, N. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal.lung cancer and phenechromocytoma. Journal of Clinical Endocrinology and Metabolism 1984 , 58:919-924.

90. Cummings, S.; Elde, R.; Ell, J.; Lendall, A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study. Journal of Neuroscience 1983, 3:1355-1368.

91. Valentino, RJ. CRH effects on central noradrenergic neurons:Relationship to stress. In: Chrousos, GP.; Loriaux, DL.; Gold,PW., eds. Mechanisms of physical and emotional stress. Advances in experimental medicine and biology, vol. 245. New York:Plenum Press; 1988:47-64.

92. Ganong, WE. The stress response-a dynamic overview. Hospital Practice 1988, 93:155-171.

93. Calogero AE.; Bernardini R.; Gold PW.; Chrousos GP.Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: Potential clinical implications. In: Chrousos GP.; Loriaux DL.; Gold PW., eds. Mechanisms of physical and emotional stress. Advances in experimental medicine and biology. New York: Plenum Press; 1988, vol. 245, 167-181.

94. Bernardini, R,; Calogero, AE.; Ehrlich YH.; Brucke T.; Chrousos GP.; Gold. PW. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary adrenal axis in the rat. Endocrinology .1989.1:1067-1073.

314

Bibliography

95. Cruse JM.; Lewis RE., eds. The year in immunology 1988:Vol. 5. Immunoregulatory cytokines and cell growth. Basel: Karger ;1988: 205-217.

96. Woloski BRMNJ.; Smith EM.; Mejer WJ. Ill; Fuler,G. M.; Blalock, J. E. Corticotropin releasing activity of monokines. Science 1985,230:1035-1037.

97. Fisher LA.; Rivier J.; Rivier C; Speiss, J.; Vale, W.; Brown,MR. Corticotropin releasing factor (CRF): Central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982,110: 2222-2224.

98. Gardiner SM.; Compton AM.; Bennett T. Cardiovascular instability induced by intracerebroventricular administration of vasopressin or corticotrophin-releasing factor in conscious Long Evans and Brattleboro rats. Journal of Neuroendocrinology 1990, 2: 39-43.

99. Sutton R E.; Kooh GF.; Le Moal M.; Rivier J.; Vale W. Corticotropin releasing factor (CRF) produces behavioural activation in rats. Nature.\9%2, 297:331-333.

100. Britton, DR, Koob GF.; Rivier J.; Vale W. Intraventricular corticotropin-releasing factor enhances behavioural effects of novelty. Life Sciences. 1982,31:363-367.

101. Britton DR.; Lee G.; Dana R.; Risch SC; Koob GF. Activiating and "anxiogenic" effects of corticotropin-releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life SciencesA9S6, 39:1281-1286.

102. Sutton, RE.; Kooh, GF.; Le Moal, M.; Rivier, J.; Vale , W. Corticotropin releasing factor (CRF) produces behavioural activation in rats. Nature 1982,297:331-333.

103. Koob, GF.; Bloom, FE. Corticotropin-releasing factor and behavior. Federation proceedings 1985,44:259-263.

104. Sirinathsinghji, DJS.; Rees, LH.; Rivier, J.; Vale, W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983,305:232-235.

105. Morely, JE.; Levine, AS. Corticotropin-releasing factor, grooming and ingestive behavior Life SciencesA9S2, 31:1459-1464.

106. Fuxe, K.; Wikstrom, A.; Okret, S.; Agnati, L.; Harfstrand, A.;Yu, Z.; Granholm, L.; Zoli, M.; Vale, W.; Gustafsson, J., et aLMapping of glucocorticoid receptor immunoreactive neurons in the rat tel and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985, 117: 1803-1812.

107. Reul, J.; DeKloet, E. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation Endocrinology 1985, 177:2505-2511.

108. Sapolsky, R.; Krey, LC; McEwen, B. S. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocrine Reviews 1986 ,7: 284-301.

109. McEwen, BS.; Weiss, J.; Schwartz, L. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968,220:911-912.

110. Sapolsky, R.; Krey, L.; McEwen, B. Corticosterone receptors decline in a site-specific manner in the aged rat brain. Brain Research 1983,289:235-240.

111. Rigter, J.; Veldhuis, H.; De Kloet, E. Spatial orientation and the hippocampal corticosterone recptor systems of old rats; Effect of ACTI-I4_ 9 analogue ORC2766. Brain Research 1984,309:393-398.

112. McEwen, BS.; Weiss, J.; Schwartz, L. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220:911-912.

315

Bibliography

113. Rigter, J.; Veldhuis, H.; De Kloet, E. Spatial orientation and the hippocampal corticosterone recptor systems of old rats; Effect of ACTI-I4_ 9 analogue ORC2766. Brain Research.l9&4,309:393-398.

114. Sapolsky, R.; Krey, L. C ; McEwen, B. S. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis Endocrine. Reviews, 1986, 7:284-301.

115. Sapolsky, R. Glucocorticoid toxicity in the hippocampus: Temporal aspects of neuronal vulnerability. Brain Research 1985,359:300-305.

116. Sapolsky, RM. Endocrine and behavioral correlates of drought in wild olive baboons (Papio anubis). American Journal of Primatology 1986,11:217-227.

117.Sapolsky, R.; McEwen, BS. Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone. Brain Research.1985,339:161-165.

118. Gold, PW.; Goodwin, FK.; Chrousos, GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress, (first of two parts).The New. England Journal of. Medicine.19%8,319:348-353.

119. Gold, PW.; Goodwin, FK.; Chrousos, GP. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress, (second of two parts). The New England Journal of Medicine 1988 , 319: 413-420.

120. Gold, PW.; Loriaux, DL.; Roy, A.; Kling, MA.; CalabreseJ. R.; Kellner, C. H.; Nieman, L. K.; Post, R. M.; Pickar, D.;Gallucci, W.; Avgerinos, P.; Paul, S.; Oldfield, E. H.; Cutler, G. B.; Chrousos, G. P. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. The New England Journal of Medicine 1986 , 314:1329-1335.

121. Sachet, RJ.; Hellman, C ; Roffwarg, HP.; Halpern, FS.;Fukushima, DK.; Gallagher, TF. Disrupted 24-hour patterns of Cortisol secretion in psychotic depression Achieves of. General Psychiatry 1973 , 28:19-24.

122. Weiss, J. M.; Stone, E. A.; Hanell, N. Coping behavior and brain norepinephrine levels in rats. Journal of Comparative and Physiological Psychology.,1970 , 72:153-160.

123. Weiss, JM.; Goodman, PA.; Losito, BG.; Corrigan, S.;Chatty, JM.; Baily, WH. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamineand serotonin levels in various regions of rat brain. Brain Research Review. 1981 , 3:167-205.

124. Dilsaver, SC. Effects of stress on muscarinic mechanisms. Neuroscience and behavioural reviews 1988 , 12:23-28.

125. Dilsaver SC; Alessi, N. E. Chronic inescapable foot shock produces cholinergic system supersensitvity Biological. Psychiatry 1987, 22:914-918.

126. Janowsky, DS.; El-Yousef, M. K.; Davis, J. H.; Sereke, H. S.A cholinergic adrenergic hypothesis of mania and depression. Lancet 1972, 19:675-681.

127. Janowsky, DS.; Risen, S. C. Acetylcholine hypothesis of stress modulation. Integrative Psychiatry 1985, 3:3-9.

128. Janowsky, DS.; Risch, SC. Cholinomimetic and anticholinergic drugs used to investigate a cholinergic hypothesis of affective disorders and stress. Drug Development Review 1984,4:125-142.

129. Harris, GW. Neural control of the pituitary gland. Physiological Reviews 1948, 28: 134-179.

130. Hatfield, JM.; Daikh , DL; Adelman , JP.; Douglass, J.; Bond ,CT.; Allen, RG. In situ hybridization detection of marked differences in pre-proopiomelanocortin messenger ribonucleic acid content of individual corticotropes and melanotropes. Endocrinology 1989,124:1359-1364.

316

Bibliography

131. Calogero, AE.; Kamilaris. TC; Gomez, MT.; Johnson, EO.; Tartaglia, ME.; Gold, PW.; Chrousos, GP. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamicpituitary- adrenal axis through a centrally-mediated corticotropinreleasing hormone-dependent mechanism. Endocrinology 1989, 125:2:44-2453.

132. Kennedy, S.; Thompson, R.; Stancer, HC; Roy, A.; Persad, E.Life events precipitating mania. British. Journal of Psychiatry 1983,142:398-403.

133. Lloyd, C. Life events and depressive disorder: U. Events as precipitating factors. Archives of General Psychiatry 1980, 37:541-548.

134. Ranke, MB.; Pfluger, H.; Rosendahl, W., et al. Turner syndrome:Spontaneous growth in 150 cases and review of the literature. European. Journal of Pediatrics. 1983,141:81-88.

135. Linder, B.; Cassorla, F. Short stature: Etiology, diagnosis, and treatment. JAMA 1988,260:3171-3175;

136. Cacciari, E.; Salardi, S.; Lazzari, R., et al. Short stature and celiac disease: A relationship to consider even in patients with nogastrointestinal symptoms. Journal of Pediatrics. 1983,103:708-711.

137. Groll, A.; Preece, MA.; Candy, DCA., et al. Short stature as the primary manifestation of celiac disease. Lancet 1980,2:1097-1105.

138. Isaksson, OGP.; JanssonJO.; Gansel, AM. Growth hormone stimulates longitudinal bone growth directly. Science 1982,216:1237-1241.

139. Powell, GF.; Brasel, JA.; Blizzard, RM. Emotional deprivation and growth retardation simulating idiopathic hypopituitarism.Clinical evaluation of the syndrome. The New England Journal of Medicine 1967, 276:1271-1278.

140. Money, J. The syndrome of abuse dwarfism (psychosocial dwarfism or reversible hyposomatotropinism): Behavioral data and case report. American Journal of Diseases of Children 1977,131:508-513.

141. Money, J.; Annecillo, C ; Kelley, JF. Abuse-dwarfism syndrome After rescue, statural and intellectual catchup growth correlate. Journal of Clinical Child Psychology. 1983 (129,130), 12:279-283.

142. Alexlrod, J.; Reisine, TD. Stress hormones: Their interaction and regulation. Science 1984 , 224: 45-459.

143. Green, W. H. A theoretical model for classical psychosocial dwarfism (psychosocial^ determined short stature). In: Holmes, C. S.,ed. Psychoneuroendocrinology: Brain, behavior and hormonal interactions.New York: Springer-Verlag; 1990:92-112.

144. Ono, N.; Lumpkin, MD.; Samson, WK.; McDonald, JK.;McCann, SM. Intrahypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat. Life Sciences 1984, 35:1117-1123.

145. Rivier, C; Vale, W. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology 1984,114: 2409-2411.

146. Blalock, JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiological Review 1989, 69:1-32.

147.Van Liessum, PA.; Swinkels, LM.; Pieters, GF.; Ross, AA.; Smals, AG.; Benraad, TJ.; Kloppenborg, PW. Lack of antibody formation during long-term subcutaneous treatment with the somatostatin analogue octreotide in acromegaly. Acta Endocrinology (Copenh.) 1990,122 : 309-312.

148. Weigent, DA.; BlalockJE. Interactions between the neuroendocrine and immune systems: Common hormones and receptors. Immunological Review 100 : 79-100; 1987.

317

Bibliography

149. Bateman. A.; Singh, A.; Krai, T.; Solomon, S. The imraune-hypothalamic-pituitary-adrenal axis. Endocrine

Review 1989,10:92-112.

150. Munck, A.; Guyre, P.; Holbrook, N. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Review 1984, 5:25-44.

151. Besedovsky, JO.; del Rey, AE,; Sorkin, E. Neuroendocrine immunoregulation. In: Fabris, W.; Garaci, E.; Hadden, J., eds. Immunoregulation. London: Plenum Press; 1983.

152. Gillis, S.; Crabtree, GR.; Smith, KA. Glucocorticoid induced inhibition of T cell growth factor production I. The effect of mitogen induced lymphocyte proliferation. Journal of immunology 1979,123:1624-1631.

153. Haynes, BF.; Fanci, AS. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. Journal of Clinical Investigation 1978, 61:703-707.

154. Marsh, JT.; Rasmussen, AF. Response of adrenals, thymus,spleen and leukicytes to shuttle box and confinement stress. Proceedings of the Society for Experimental Biology and Medicine 1960,104:180-183.

155. Monjan, AA. Stress and immunologic competence: Studies in animals. In: Ader, R., ed. Psychoneuroendocrinology New York: Academic Press; 1985, 185.

156. Munck, A.; Guyre, PM. Glucocorticoid physiology, pharmacologyand stress. In: Chrousos, GP.; Loriaux, D. L.; Lipsett, M.B., eds. Steroid hormone resistance. New York: Plenum Press ; 1986 , 81-96.

157. Steinberg, EM. Monokines, lymphokines, and the brain. In:Cruse, JM.; Lewis, RE., eds. The year in immunology 1988: Vol. 5. Immunoregulatory cytokines and cell growth. Basel: Karger;

158. Blalock, JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiological Review 1989, 69:1-32.

159. Weigent, DA.; Blalock, JE. Interactions between the neuroendocrine and immune systems: Common hormones and receptors. Immunological Reviews 1987, 100:79.

160. Cacciari, E.; Salardi, S.; Lazzari, R., et al. Short stature and celiac disease: A relationship to consider even in patients with no gastrointestinal symptoms. Journal of Pediatrics 1983,103 :708-711.

161. Adams, MR,; Kaplan, JR.; Koritnik, DR. Psychosocial influences on ovarian endocrine and ovulatory function in Macaca facicularis. Physiology and Behaviour 1985, 35:935-940.

162. Bachman, GA.; Kemmann, E. Prevalence of oligomenorrhea and amenorrhea in a college population. American Journal of Obstetrics Gynecology 1982 , 1'44:98-102.

163. Broadhurst, PL. Experiments in psychogenetics applications of biomedical genetics to the inheritance of behavior. In: Eysenck, H.J., ed. Experiments in personality psychogenetics and psychopharmacology,vol. 1. London: Routledge and Keegan Paul; 1960:1-102.

164. Loucks, AB.; Mortola, JF.; Girton, L.; Yen, SC. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. The Journal of Clinical Endocrinology and Metabolism 1989,68:402-411.

165. Abbott, DH. Behaviorally mediated suppression of reproduction in female primates. Journal of Zoology. (Lond.).1987,213:455-470.

166. Collu, R.; Gibb, W.; Ducharme, JR. Effects of stress on the gonadal function. Journal of Endocrinological Investigation 1984, 7:529-537.

318

Bibliography

167. Rabin, D.; Gold, PW.; Margioris, AN.; Chrousos, GP. Stress and reproduction: Physiologic interactions between the stress and reproductive axes. In: Chrousos, GP.; Loriaux, DL.; Gold, PW., eds. Mechanisms of physical and emotional stress, vol 245.Advances in experimental medicine and biology. New York: Prenrice-Hall; 1988:377-387.

168. Sapolsky, R.; Krey, LC; McEwen, BS. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocrine Reviews 1986, 7:284-301.

169. Doerr, P.; Pirke, KM. Cortisol-induced suppression of plasma testosterone in normal adult males. Journal of Clinical Endocrinology and Metabolism 1976,43:622-629.

170. Hagino, N.; Watanabe, M.; Goldzieher, JW. Inhibition by adrenocorticotrophin of gonadotrophin-induced ovulation in immature female rats. Endocrinology 1969, 84:308-314.

171. Rivier, C ; Vale, W. Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 1984, 114:914-921.

172. Rivier, C ; Rivier, J.; Vale, W. Stress-induced inhibition of reproductive functions: Role of endogenous corticotropin-releasing factor. Science 1986,231:607-609.

173. Sirinathsinghji, DJS.; Rees, LH.; Rivier, J.; Vale, W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983,305:232-235.

174. Vreeburg, JTM.; De Greef, WJ.; Ooms, MP.; Van Wouw,P.; Weber, RFA. Effects of adrenocorticotropin and corticosterone on the negative feedback action of testosterone in the adult male rat. Endocrinology 1984, 115(3):977-983.

175. Hagino, N.; Watanabe, M.; Goldzieher, JW. Inhibition by adrenocorticotrophin of gonadotrophin-induced ovulation in immature female rats. Endocrinology 1969, 84:308-314.

176. Bambino, TH.; Hsueh, AJW. Direct inhibitory effect of glucocorticoids upon testicular luteinizing hormone receptor and steroidogenesis in vivo and in vitro. Endocrinology 1981,108:2142-2148.

177. Charpenet, G.; Tache, Y.; Forest, MG.: Haour, F.; Saez, JM.;Bemier, M.; Ducharme, JR.; Collu, R. Effects of chronic intermittent immobilization stress on rat testicular androgenic function. Endocrinology 1981, 109(4): 1254-1258.

178. O'Byrne, KT.; Lunn, SF.; Dixson, AF. Effects of acute stress and the patterns of LH secretion in the common marmoset (Callithrixjacchus). Journal of Endocrinology 1988,118:259-264.

179. O'Byrne, K. T.; Lunn, S. F.; Dixson, A. F. Naloxone reversal of stress-induced suppression of LH release in the common marmoset. Physiology and Behaviour 1989,45:1077-1080.

180. Baldwin, DM.; Sawyer, CH. Effects of dexamethasone on LH release and ovulation in the cyclic rat. Endocrinology 1974, 94:1397-1403.

181. Kamilaris, TC; DeBold, CR.; Johnson, EO.; Mamalaki, E.;Listwak, SJ.; Calogero, AE.; Kalogeras, KT.; Gold, PW.;Orth, DN. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 1991,128:2567-2576.

182. Rabin, DS.; Johnson, EO.; Brandon, DD.; Liapi, C ; Chrousos.GP. Glucocorticoids inhibit estradiol-mediated uterine growth:Possible role of the uterine estradiol receptor. Biology of Reproduction 1990,42:74-80.

183. Pollard, I.; Dyer, SL. Effect of stress administered during pregnancy on the development of fetal testes and their subsequent function in the adult rat. Journal of Endocrinology 1985, 188:241-245.

319

Bibliography

184. Pollard, I. Prenatal stress effects over two generations in rats. Journal of Endocrinology 1986, 109:239-244.

185. Bassen, JJ,; Thorburn, G. D. Foetal plasma corticosteroids and the initiation of arturition in the sheep. Journal of Endocrinology 1969,44:285-286.

186. Howarth, B., Jr.; Hawk, HW. Effect of hydrocortisone on embryonic survival in sheep. Journal of Animal. Science 1968, 27:117-121.

187. Liggens, G. C ; Fairclough, R. J.; Grieves, S. A.; Kendall, J. W.,et al. The mechanism of parturition in the ewe. Recent Progress in Hormone Research 1973,29:111-150.

188. 192.Gais S, Born J. Declarative memory consolidation: mechanisms acting during human sleep. Learning and Memory 2004; 11: 679 - 85

189. Hendrickx H, McEwen BS, van der Ouderaa F. Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention. Neurobiology of Aging 2005; 26 S: SI - S5.

1%. Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology 2004 ; 61:661- 6.

191. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. Journal of Gerontology 2004; 59 A: 178- 83.

192. Tsuno N, Besset A, Ritchie K. Sleep and depression. Journal of Clinical Psychiatry 2005 ; 66:1254- 69.

193. Dubrovsky BO, Liquornik MS, Noble P, Gijsbers K. Effects of 5_-dihydrocorticosterone on evoked responses and long-term potentiation. Brain Research Bulletin 1987, 19: 635-8.

194. Filipini D, Gijsbers K, Birmingham MK, Dubrovsky B. Effects of adrenal steroids and their reduced metabolites on hippocampal long-term potentiation. Journal of Steroid Biochemistry and Molecular Biology 1991 ; 40:87-92.

195. Pavlides C, Watanabe Y, McEwen BS. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993, 3:183-92.

196. Bennett MC, Diamond DM, Fleshner M, Rose GM. Serum corticosterone level predicts the magnitude of hippocampal primed burst potentiation and depression in urethane-anesthetized rats. Psychobiology 1991, 19:301-7.

197. Diamond DM, Bennett MC, Fleshner M, Rose GM. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 1992, 2: 421-30.

198. Bohus B. Central nervous structures and the effect of ACTH and corticosteroids on avoidance behaviour: a study with intracerebral implantation of corticosteroids in the rat. Progress in Brain Research 1970, 132: 171-84.

199. Bohus B, Lissak K. Adrenocortical hormones and avoidance behaviour of rats. International Journal of Neuropharmacology 1968 ; 7:301-6.

200. Greidanus TJB. Effects of steroids on extinction of an avoidance response in rats. A structure-activity relationship study. Progress in Brain Research 1970, 32: 185-91.

201. Roozendaal B, McGaugh JL. The memory-modulatory effects of glucocorticoids depend on an intact stria terminalis. Brain Research 1996, 709: 243-50.

320

Bibliography

202. Kovacs GL, Telegdy G, Lissak K. 5-Hydroxytryptamine and the mediation of pituitary-adrenocortical hormones in the extinction of active avoidance behavior. Neuroendocrinology 1976,1:219-30.

203. Lupien SJ, McEwen BS. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Research Reviews 1997; 24:1-27.

204. McEwen BS, Dekloet ER, Rostene W:Adrenal steroid receptors and actions in the nervous system. Physiological Reviews 1986,66: 1121-1188.

205. Pavlides C, Kimura A, M agarinos AM, M cEwen BS: Type I adrenal steroid receptors prolong hippocampal long-term potentiation. Neuroreport 1994,5: 2673-2677.

206. Pavlides C, W atanabe Y, M cEwen BS:Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993, 3: 183-192.

207. Pavlides C, Kimura A, M ararinos AM, M cEwen BS:Hippocampal homosynaptic long-term depression/depotentiation induced by adrenal steroids. Neuroscience 1995, vol.68, Issue 2:379-385.

208. Sapolsky ^Glucocorticoids, stress and exacerbation of excitotoxic neuron death. Seminars in Neuroscience 1994, 6: 323-331.

209. Kadekaro M, M asanori I, Gross P.Local cerebral glucose utilization is increased in acutely adrenalectomized rats. Neuroendocrinology 1988,47: 329-336.

210. Freo U, Holloway H, Kalogeras K, Rapoport S, Soncrant T:Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist DOI in the hippocampus. Brain Research 1992, 586: 256-263.

211. Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B:Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. American Journal of Physiology 1993,264: 29-35. 31.

212.214. Doyle P, Guillaume-Gentile C, Rohner-Jeanrenaud F, Jeanrenaud B:Effects of corticosterone administration on local cerebral glucose utilization of rats. Brain Research 1994, 645: 225-230.

213. Horner H, Packan D, Saplosky R:Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990, 52: 57-63.

214. Virgin C, Ha T, Packan D, Tombaugh G, Yang S, Horner H, Sapolsky R:Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. Journal of Neurochemistry 1991, 57: 1422-1428.

215. Horner H, Packan D, Saplosky R:Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990, 52: 57-63.

216. Horner H, M unck A, Lienhard G:Dexamethasone causes translocation of glucose transporters from the plasma membrane to an intracellular site in human fibroblasts. The Journal of Biological Chemistry 1987, 262: 17696-17703.

217. Garvey W, Huecksteadt T, Lima F, Birnbaum M:Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: dexamethasone decreases transporter mRNA in primary cultured adipocytes. Molecular Endocrinology 1989, 3: 1132-1138.

218. Selye, H. Studies on adaptation. Endocrinology 1937; 21/2:169.

219. Selye, H. Adaptation energy : Nature. 1938;141: 926.

220. Brekhman, 1.1. (1980). Man and Biologically Active Substances. Pergamon Press, Oxford.

321

Bibliography

221. Lazarev NV. General and specific in action of pharmacological agents. Farmacol Toxicol 1958,21: 81-6.

222. David Winston and Steven Maimes Adaptogens :Herbs for strength, stamina and stress relief Healing arts press 2007,p21.

223. Wagner, H.: Dtsch. Apoth. Ztg. 1991; 131/4:117.

224. Moller, HJ., und Horn, R.: ApothJ. 1999;12:14.

225. Ha, Z., Zhu, Y., Zhang, X., Cui, J., Zhang, S., Ma, Y., Wang, W., Jian, X,. The effect of Rhodiola and acetazolamide on the sleep architecture and sleep blood oxygen saturation of persons living at 5380 meters above sea level. Chinese Journal of Tuberculosis and Respiratory Diseases. 2002,21, 1-6.

226. Petkov, V.D., Yonkov, D., Mosharoff, A., Kambourova, T., Alova, L., Petkov, V.V., 1986.Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiology. Pharmacology. Bulg. 1986, 12,3-16.

227. Bombardelli, E., Cristoni, A., Lietti, A., 1980. The effect of acute and chronic ginseng saponins treatment on adrenals function: Biochemical and pharmacological aspects. In:Proceedings of 3rd International Ginseng Symposium. Korea Ginseng Research Inst.Seoul, Korea, pp. 9-16;

228. Hasan Samira, MM., Attita Attita, M., Allam, M., Elwan, O. Effect of the standardized ginseng extract Gl 15 on the metabolism and electrical activity of the rabbit's brain. Journal of International. Medical Resarch. 1985,13, 342-348

229. Panossian, A., Oganessian, A., Ambartsumian, M., Gabrielian, E., Wagner, H., Wikman, G. Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine 1999c ,6, 17-26.

230. Kochetkov NK,KhorlinAY, ChizhovOS, SheichenkoVI. Chemical investigation of Schisandra chinensis: Communication 2. Structure of Schizandrin. IzvestiyiaAkademiiNaukSSSR, Seriya Khimicheskaya 1962; No. 5:850-856.

231. KurkinVA, ZapesochnayaGG. The chemical composition and pharmacological Properties of plants of the genus Rhodiola. Khimiko Farmatsevticheskii Zhurnal 1986; 20 (10):1231-1244.

232. Norr H. Phytochemical and Pharmacological Investigations of the Adaptogens: Eleutherococcus senticosus, Ocimum anctum, Codonopsis ilosula, Rhodiola rosea.and Rhodiola crenulata. Ph.D. Dissertation, Faculty of Chemistry and Pharmacy, Ludwig-Maximillians University, Munich,Germany, 1993.

233. Wagner H. Immunostimulants and adaptogens from plants. In: Amason JT, et al.,eds., Phytochemistry of Medicinal plants. NewYork:Plenum Press, 1995:1-18.

234. Elyakov GB, Ovodov YS. He glycosides of raliaceae. Khimia Prirodnich Soedineniy 1972; Issue No. 6:697-709.

235. Panossian A, Gabrielian E, Wagner H. Plant adaptogens II: Bryonia as an adaptogen. Phytomedicine 1999;4(1):85-99.11,

236. Panossian A, Gabrielian E, Wagner H. On the mechanism of action of Plant adaptogens with particular references on cucuirbitacin R diglucoside. Phytomedicine 1999;6(3): 147-155]

237. PanossianAG Pashinian SA, Gasparian GV, et al. Cucurbitacine glucosidesand trihydroxyoctadecadienoic acids—New tonic compounds from Bryonia alba L. roots. In: New Data About Eleutherococcus and Other Adaptogens. Vladivostok: Dalne Vostochniy Filial Sibirskogo Onteleniya Academii Nauk SSSR, 1981:149-154.

322

Bibliography

238. Panossian AG, Avetissian GM, Mnatsakanian VA, et al. UnsaturatedPolyhydroxy fatty acids having prostaglandin-like activity from Bryonia alba L.: Major components. Planta Medica 1983;47:17-25.7

239. Panossian AG, Dadayan MA, Karaguezian KG, Gevorkyan GA. Content Of prostaglandins E2, F2 and 5-hydroxyeicosatetraenoic acid in bloodOf immobilized rats and effect of dihydrocucurbitacin D diglucoside. Voprosi Medicinal Chemistry 1985;Issue No 6:98-99.

240. Panossian AG. Influence of cucurbitacins of Bryonia alba on theBiosynthesis of eicosanoids in human leukocytes. Bioorganic Chemistry 1985; Issue No. 11:264-269.

241. Panossian AG, Dadayan MA, Gabrielian ES. Cucurbitacin R glucoside As a regulator of steroidogenesis and production of prostaglandin E2—A Specific modulator of hypo-thalamus-pituitary-adrenal cortex system. Bulletin of Experimental Biology and Medicine 1987; Issue No. 53:456-457.

242. Sprygin VG, Panossian AG, Dardimov IV. Influence of Eleutherococcus And eleutherosides A,B,C,D and E on the arachidonic acid release and metabolism. Pharmaceutical Chemistry Journal 1988; Issue No. 7:776-779.

243. Kudrin AN, Rodina LG. The comparative effect of the sum of Eleutherococcus and Ginseng substances on adaptation and resistance of the central nervous system in the case of ischemia and reperfusion. In: New Data on Eleutherococcus. Vladivostok, Far East Center of the Academy Sciences of the USSR, 1986:149-153.

244. Boon Niermeijer EK, van den Berg A, Wikman G, Wiegant FAC. Phytoadaptogens Protect gainst environmental stress-induced death of Embryos from the freshwater snail Lymnea stragnalis. Phytomedicine 2000;7: 389-400.

245. Selye H. Stres. Montreal Acta Medical Publishers, 1950:1-127.

246. Hochachka PW, Somero GN. Biochemical Adaptation. Princeton, NJ: Princeton University Press, 1984:1— 356.

247. Meerson F.Adaptation, Stress and Prophylaxis Russian Edition: Moscow: Nauka, 1981; New York: Springer-Verlag, 1984:1-278.

248. Malishev IY, Manukhina EB. Stress, adaptation and nitric oxide Biochimia 1998; 63(7):992-1006.

249. Deyama T, Nichibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacologica Sinica 2001,22:12; 1057-70.

250. Chen Q et al. Effects of Rhodiola rosea on body weight and intake of sucrose and water in depressive rats induced by chronic mild stress. J Chinese Integr Med 2008,(6):9:952-5.

251. Mirjalili MH, MoyanoE, Bonfill M, Cusido RM, Palazon J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 2009, (14) 7: 2373-93.

252. Li TSC, Mazza G, Cottrell AC, Gao L. Ginsenosides in roots and leaves of American ginseng. Journal of Agricultural Food and Chemistry. 1996;44: 717-720

253. Lee JH, Choi SH, Kwon OS, et al. (November 2007). Ginsenoside (American) "Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegans". Biological & Pharmaceutical Bulletin 2007,30 (11): 2126-34.

254. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera.. Indian Journal of Experimental Biology. 1997; 35:236-239.

255. Brekhman II, Kirillov OI. Effect of Eleutherococcus on alarm-phase of stress. Life Sciences, 1969, 8:113-121.

323

Bibliography

256.258. Ghosal S., V.K. Triphati and S. Chauhan, Active constituents of Emblica officinalis: Part 1- The chemistry and antioxidative effects of two new hydrolysable tannins, Emblicanin A and B, Indian J. ofChem., 35B, 941-948,1996

257. Leung, AY, Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. 2nd ed. Toronto/New York: John Wiley and Sonslnc; 1996: 649

258. Shirataki Y, Takao M, Yoshida S, Toda S. Antioxidant components isolated from the roots of astragalus membranaceus bunge (astragali radix). Phytotherapy Research 1997; 11:603-5.

259. Ghosal S, Reddy JP, Lai VK. Shilajit: Chemical constituents. Journal of Pharmaceutical sciencsi 1976, 65: 772-773

260. Jung CH, Jung H, Shin YC, et al. Eleutherococcus senticosus extract attenuates LPS-induced iNOS expression through the inhibition of Akt and JNK pathways in murine macrophage. Journal of Ethnopharmacology 2007; 113: 183-7.

261. Wiegant FAC, Surinova S, Ytsma E, Langelaar-Makkinje M,Wikman G, Post JA. Plant adaptogens increase life span and stress resistance in C. elegans. Biogerontology 2009 ;10: 27-42.

262. Ip SP, Che CT, Kong YC, Ko KM. Effects of schizandrin B pre-treatment on tumor necrosis factor-alpha induced apoptosis and Hsp70 expression in mouse liver Cell. Stress Chaperones 2001; 6: 44-8.-

263. 275. 279.271.259.Chiu PY, Ko KM. Schisandrin B protects myocardial ischemiareperfusioninjury partly by inducing Hsp25 and Hsp70 expressionin rats. Molecular and Cellular Biochemistry 2004; 266: 139-44

264. Abidov M, Crendal F, Grachev S, Seifulla R, Ziegenfuss T. Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bulletin of Experimental biology and medicine 2003; 136: 585-7.

265. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochimica Biophysica Acta 2001; 1504: 46-57.

266. Hara MR, Cascio MB, Sawa A. GAPDH as a sensor of NO stiess.Biochimica Biophysica Acta 2006; 1762: 502-9.

267. Panossian A, Hambartsumyan M, Hovanissian A, Gabrielyan E.Wikman G. The adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and Cortisol. Drug Target Insights 2007; 1: 39-54.].

268. Munk A. Corticosteroids and stress. In: Fink G Ed. Encyclopaedia of stress, vol. 1. San Diego, Academic Press 2000; pp. 570-7.

269. Young AH. Cortisol in mood disorders. Stress 2004; 7: 205-8.

270. Chan ED, Riches DW. UN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. American Journal of Physiology- Cell Physiology. 2001; 280: C441-50.

271. Lin QY, Jin LJ, Ma YS, Shi M, Xu YP. Acanthopanax senticosus inhibits nitric oxide production in murine macrophages in vitro and in vivo. Phytotherapy Research 2007; 21: 879-83.

272. Panossian A, Wikman G, Kaur G, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine 2009, 16: 617-622.

273. Panossian A, Wikman G, Andreeva L, Boykova A, Nikiforova D.Timonina N. Adaptogens exert a stress protective effect by modulation of expression of molecular chaperons. Planta Medica 2008; 74:1018

324

Bibliography

21 A. Narimanian M, Badalyan M, Panosyan V, et al. Impact of ChisanR (ADAPT 232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. Phytomedicine 2005; 12: 723-9.

275. Panossian A, Wikman G. Effect of adaptogens on the central nervous system. Arquivos Brasileiros de Fitomedicina Cientifica. 2005,2: 109-131

276. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytothearapy Research 2002, 16: 639-645.

277. Davis L, Kuttan G. Imunomodulatory activity of Withania somnifera. Journal of Ethnopharmacology 2000, 71: 193-200.

278. Mediratta PK, Sharma KK, Singh S. Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action. Journal of Ethnopharmacology 2002, 80: 15-20.

279. Kimura Y, Sumiyoshi M. Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice. Journal of Ethnopharmacology 2004, 95:447-453.

280. Kvetnansky R, Pacak K, Fukuhara K, Viskupic E, Hiremagalur B, Nankova B, Goldstein DS, Sabban EL, Kopin IJ. Sympathoadrenal system in stress; interaction with the hypothalamic-pituitary-adrenocortical system. Annals of the New York Academy of Sciences 1995 ,771: 131-158;

281. Carrasco GA, van de Kar LD. Neuroendocrine pharmacology of stress. European Journal of Pharmacology 2003 ,463:235-272.

282. Harman D Free-radical theory of aging. Increasing the functional life span. Annals ofNewYork Academy of Science 1994,717: 1-15. Moosmann & Behl, 2002.

283. Di- Matteo V, Esposito E. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Current Drug Targets - CNS & Neurological Disorders 2003,2: 95-107.

284. Bridi R, Crossetti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Ginkgo biloba (EGB 761) in rats. Phytotheapyr Research 2001,15: 449-451.

285. Hancke JL, Burgos RA, Ahumada F. Schisandra chinensis (Turcz.) Baill. Fitoterapia 1999, 70: 451-471.

286. Chen TS, Liou SY, Chang YL. Antioxidant evaluation of three adaptogen extracts. American journal of Chinese Medicines. 2008 ,36: 1209-1217.

287. Lin CC, Huang PC. Antioxidant and hepatoprotective effects of Acathopanax senticosus. Phytotherapy Research .2000, 14: 489-494.

288. Petkov VD, Belcheva S, Petkov W . Behavioral effects of Ginkgo biloba L., Panax ginseng C.A. Mey. and Gincosan. American journal of Chinese Medicines.2003,31: 841-855;

289. Liu JX, Cong WH, Xu L, Wang JN 2004. Effect of combination of extracts of ginseng and Ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC. Acta Pharmacologica Sinica. 2004,25: 1118-1123.

290. Tachikawa E, Kudo K. 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. Journal of Pharmacological Sciences. Jun 2004, 95:2; 140-44.

325

Bibliography

291. Kaneko H, Nakanishi K, 2004. Proof of the mysterious efficacy of Ginseng: basic and clinical trials: clinical effects of medical ginseng, Korean red ginseng: specifically its antistressaction for prevention of disease. Journal of Pharmacological Sciences, Jun.2004 95:2;158-62.

292. Kathy abascal and Eric Yamell Increasing vitality with Adaptogens: Multifaceted Herbs for treating physical and mental stress, Alternative and complementary therapies, April 2003,Vol.9,No.2:54-60

293. Joshi T., Shah S.P., Singh A. Antistress activity of ethanolic extract of Asparagus racemosus willd roots in mice Indian Journal of experimental biology. June 2012, Vol.50,419-424

294. Panossian alexander GAdaptogens :tonic Herbs for Fatigue and stress Alternative and complementary therapies, December 2003,Vol. 9,No 6: 327-331

295. Oganesyan KR. Antioxidant effect of licorice root on blood catalase activity in vibration stress. Bulletin of Experimental biology and Medicine. 2002 ,134:2;135-36.

296. Jong-Ho KOH, Kyung-Mi Kim, Jin-Man Kim, Jae-Chul Song,Suh HJ.Antifatigue and antistress effect of the hot watyer fraction of mycelia of cordyceps sinesis Biological and pharmaceutical Bulletin. 2003,26: 691-694.

297. 299.Spasov AA et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000, 7:2; 85-89.

298. Kelly G.S. 2001. Rhodiola rosea: a possible plant adaptogen. Alternative Medicine Review 6:293-302.

299. Xia Q, Xiao P, Wan L, Kong J.. Ethnopharmacology of Phyllanthus emblica L. Journal of Chinese Material Medica. 1997 ,22(9):515-18, 525, 574.

300. Blumert, Michael; Jialiu Liu (2003). Jiaogulan: China's "Immortality" Herb. Badger, CA: Torchlight Publishing. pl2

301. Lu J.M., Yao Q., Chen C , Ginseng compounds : an update on their molecular mechanisms and medical applications Current Vascular Pharmacology. 2009,7(3): 293-302.

302. Rai D et al. Anti-stress effects of Ginkgo biloba and Panaxginseng: a Comparative Study. Journal of Pharmacological sciences. 2003 , 93: 458-64.

303. Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia. 2000,71 ;S1-S5.

304. Shah ZA, Gilani RA, Sharma P, Vohora SB. Cerebroprotective effect of Korean ginseng tea against global and focal models of ischaemia in rats. Journal of Ethnopharmacology. 2005,101:299-307.

305. Kim SH, Park KS, Chang MJ, Sung JH. Effects of Panax ginseng extract on exercise-induced oxidative stress. The Journal of Sports Medicine and Physical Fitness. 2005,45:178-82.

306. de Oliveira ACC, Perez AC, Prieta JG, Duarte IDG, Alvarez Al.. Protection of Panax ginseng in injured muscles after eccentric exercise. Journal of Ethnopharmacology. 2005, 97: 211-14.

307. Ferrando A, Vila L, Voces JA, Cabral AC, Alvarez Al, Prieto JG. Effects of standardized Panax ginseng extract on the skeletal muscle of the rat: a comparative study in animals at rest and under exercise. Planta Medica 1999, 65:239-44 ]

308. Provalova NV, Skurikhin EG, Pershina OV, Suslov NI, Minakova MY, Dygai AM et al. Mechanisms underlying the effects of adaptogens on erythropoiesis during paradoxical sleep deprivation. Bulletin of Experimental Biology and Medicine 2002a ,133:5;428-32.

326

Bibliography

309. Park JK, Namgung u, Lee CJ, Park JO, Jin SH, Kwon O-B. Calcium dependent CaMKII activity is involved in ginsenoside Rbl-mediated neuronal recovery after hypoxic damage. Life Sciences. 2005, 76:1013-25

310. Ni X-H, Ohta H, Watanabe H, Mastsumoto K. Panax ginseng extract improves scopolamine-induced deficits in working memory performance in the T-maze delayed alternation task in rats. Phytotherapy Research. 1993,7:49-52.

311. Bladt, S., Wagner, H., and Wool, W.S.: Dtsch. Apoth. Z/g.l990;130/27:1499

312. Deyama T, Nichibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacologica Sinica . 2001,22:12;1057-70

313. Yi JM, Hong SH, Kim JH, Kim HK, Song HJ, Kim HM. Effect of Acanthopanax senticosus stem on mast cell-dependent anaphylaxis Journal ofEthnopharmacology. 2002 ,79: 347-352).

314. Oates L. Siberian ginseng Eleutherococcus senticosus. Journal of Complementary Medicine. 2008, 7:4; 44-47.

315. Ssaratikov, A.S., Krasnov EA, Chnikina. LA, Duvidson LM, Sotova MI, Marina. TF et al Rhodiolosid, a new glycoside from Rhodiola rosea and its pharmacological properties. Pharmazie 1968,23: 392.

316. Zapesochnaya, G.G., Kurkin, V.A., and Shchavlinskii, A.N.: F.E.C.S. Int. Conf. Chem. Biote. chnol. Biol. Act. Nat. Prod, (proc.) 3rd Meeting Date 1985, 4,404. VCH. Weinheim, BRD, Chemical. Abstracts. 1989;110: 36720.

317. Hillhouse BJ, Ming DS, French CJ, Towers GHN. 2004. Acetylcholine esterase inhibitors in Rhodiola rosea. Pharmaceutical Biology.2004,42:l;68-72.

318. 320. Brown RP. Rhodiola rosea: A phytomedical review. Herbalgram. 2002 , 56;40-52.

319. Ohsugi M, Fan W, Hase K, Xiong Q, Tezuka Y, Komatsu K. Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra. Journal of Ethnopharmacology. 1999,67:111-19.

320. Seo WG, Pae HO, Oh GS, Kim NY, Kwon TO, Shin MK. The aqueous extract of Rhodiola sachalinensis root enhances the expression of inducible nitric oxide synthase gene in RAW264.7 macrophages. Journal of Ethnopharmacology. 2001, 76;119-23.

321. Abidov M, Grachev S, Seifulla RD, Ziegenfuss TN. Extract of Rhodiola rosea radix reduces the level of C-reactive protein and creatinine kinase in the blood. Pharmacology and Toxicology. 2004, 7:63-64.

322. Boon-Niermeijer EK, van de Berg A, Wikman G, Wiegant FAC. Phyto-adaptogens protect against environmental stress-induced death of embryos from the freshwater snail Lymnaea stagnalis. Phytomedicine 2000, 7:5;389-99.

323. Zhu B-W, Sun Y-M, Yun X, Han S, Piao M-L, Murata Y. Reduction of noise-stress-induced physiological damage by radices of Astragali and Rhodiolae: glycogen lactic acid and cholesterol contents in liver of the rat. Bioscience Biotechnology and Biochemistry. 2003, 67:9; 1930-36.

324. Kim SJ. Min HY. Lee EJ. Kim YS. Bae K. Kang SS. Lee SK. 'Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells." Phytotherapy Research. Feb 2010, 24(2): 193-197.

327

Bibliography

325. Guo LY. Hung TM. Bae KH. Shin EM. Zhou HY. Hong YN. Kang SS. Kim HP. Kim YS.,"Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill." European Journal of Pharmacology.Sep.200i,59l(l-3):293-9.

326. Xu XM, Li L, Chen M., "Studies on the chemical constituents of Schisandra pubescens". Zhong Yao Cai. Sep 2009; 32(9): 1399-401

327. Hancke JL, Burgos RA, Ahumada F. Schisandra chinensis (Turcz.) Baill. Fitoterapia 1999 ,451-71.

328. Zhu M, Lin KF, Yeung RY, Li RC. Evaluation of the protective effects of Schisandra chinensis on phase 1 drug metabolism using a CCLj intoxication model. Journal ofEthnopharmacology. 1999 ,67: 61-8.

329. Hernandez DE, Hancke JL, Wikman G. Evaluation of the anti-ulcer and anti secretory activity of extracts of Aralia elata and Schizandra chinensis fruit in the rat. Journal ofEthnopharmacology. 1988, 23: 109-14.

330. Kaur P, Sharma M, Mathur S, Tiwari, Divecar HM, Kumar R. Effect of l-oxo-5[beta], 6[beta]-epoxy-with a-2-ene-27-ethoxy-olide isolated from the roots of Withania somnifera on stress indicies in wistar rats. Journal of Alternative and Complementary Medicines. 2003,9:6; 897-907.

331. Amara S, Kumar SP, Athota RR. Suppressive effect of Withania somnifera root extract on the induction of anti-ovalbumin IgE antibody response in mice. Pharmaceutical Biology. 1999, 37:4 ; 253-9.

332. Dhuley JN.. Adaptogenic and cardioprotective action of ashwaganda in rats and frogs. Journal of Ethnopharmacology. 2000,70 ;57-63.

333. Battacharya SK, Battacharya D, Sairam K, Ghosal S. Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia. Phytomedicine. 2002, 9 ; 167-70.

334. Grandhi A, Mujumdar AM, Patwhardan B. A. comparative pharmacological investigation of ashwaganda and ginseng. Journal of Ethnopharmacoogy 1994,44:131-5.

335. Battacharya SK, Battacharya A, Sairam K, Ghosal. Anxiolyic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 2000, 7: 6; 463-9

336. Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of c hronic stress. Pharmacology Biochemistry and Behavior 2003, 75 : 547-55.

337. Kumar A, Kalonia H. 2008. Effect of Withania somnifera on sleep-wake cycle in sleep-disturbed rats: possible GABAnergic mechanism. Indian Journal of Pharmaceutical Sciences 2008, 70: 6;806-10.

338. Kour K , Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A. lnernatiional Immunopharmacology 2009, 9:10;1137-44

339. Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by Withanolide A. British Journal of Pharmacology 2005, 144:7; 961-71

340. Kirtikar KR. Basu BD. Indian Medicinal plants. Vol-I , 2nd edition, Bishen Singh Mahendra Pal Sigh, India, 1975: 472-474.

341..Nadkarni AK.The Indian Materia Medica,Vol-I,195-196.

342. Parmar, CM. Kaushal,K. Murraya Koenigii in Wild Fruits, Kalyani publisher, 1982,. 45-48.

343. Edwin EJ., Sheeja EP, Arya, H. and Bajpai A. Morpho anatomy of stems of Murraya Koenigii. Journal of biological science, 2008 ,1-5.

344. The wealth of India ,Vol-VI, CSIR ,1962.

328

Bibliography

345. Ali ,AM., Elshakawy SI, Manup F. Antimicrobial and cytotoxic properties of some malayasian traditional vegetables. International Journal of pharmacology 1997,35: 1-5.

346. .Fiebig M, Pezzutp JM, Soejarip PP and Kingham AD. Koeline A future cytotoxic carbazole alkaloid from Murraya Koenigii. Phytochemistry 1985, 24: 3041-3043.

347. The Ayurvedic Pharmacoepia of India Part - I Vol-VI, First Edition.145-147.

348. Philip, J., Curry leaf and its uses. World Crops ,1981 Nov./Dec ,125-127.

349. Noor Haslizawati Abu Akbar, Mohd. Aspollah Sukari, Mawardi Rahmani, Atan Md sharif, Kaida Khalid and Umi Kaisom Yusuf .Chemical constituents from stem barks and roots of Murrya Koenigi ,(Rutaceae),The Malaysian Journal of Analytical sciences 2007, Vol 11, No 1,173-176.

350. Khosa RL., Prasad S. Pharmacognosy of roots of Murraya Paniculata Jack and Murraya Koenigii Linn. Journal of Research in Indian Medicine 1974,93:105.

349. Kureel S.P., Kapil R.S. and Popli S.P., New alkaloids from Murrya Koenigii. Spreg. Experientia 1969 b , 25: 790.

350. Narsinhan NS., Paradkar MV., Kelkar SL. Alkaloids of Murraya Koenigii Structures of mahanine,koenine,koenigine and koenidine. Indian Journal of chemistry 1970B, Vol 8: 473.

351. Joshi BS Kamat VN. and Gawad DH. On the structures of Girinimbine , Mahanimbine , Isomahanimbine , Koenimbidine and Murrayacine. Tetrahedron 1970,26: 1475-1483.

352. Kureel SP. ,Kapil RS. and Popli SP. Terpenoid alkaloids from Murraya Koenigii SprenglV. Structure and synthesis of mahanimbinine. Experentia 1970b, 26:1055

353. Kureel SP.,Kapil RS. and Popli SP Two Novel alkaloids from Murraya Koenigii spreng Mahanimbicine and bicyclomahanimbicine. Chemical Index 1970c, No: 29,958.

354.Narsimhan NS., Paradkar MV., Chitguppi VP. and Kelkar SL. Alkaloids of Murraya koenigii: Structures of Mahanimbine , Koenimbine , mahanine , koenine , koenigine , koenidine, isomahanimbine. Indian Journal of Chemistry 1975,13: 993.

355. Anwar F., Kapil RS., Popli SP. Terpenoid alkaloids from Murraya Konigii spreg.VII synthesis of DL-O-methylmahanine and related carbazoles. Experientia 1972, 28: 769.

356. Sharma RB Seth VR and Kapil RS. Synthesis of koenigicine. Experientia 1980, 36: 815.

357. Mukherjee S., Shaw AK and Ganguly SN. Mukonicine a carbazole alkaloid from the leaves of Murraya Koenigii., Phytochemistry 1983, 22 : 2328.

358. Chakraborti M., Saha, S., Mukhopadhyay S. Murrayakoenilol- a new carbazole alkaloid from murraya Koenigii (Linn) Spreg. Natural Product Communications 2009,4(3), 355-58

359. Gupta GL and NigamSS. Chemical examination of the leaves of Murraya koenigi. Planta medica 1970 , 19:83.

360. Yun Song Wang, Hong Ping HE, Xin Hong, Qing Zhao, Xiao Jiang Hao. A New Binary Carbazole Alkaloid from Murraya koenigii. Chinese Chemical Letters 2002 ,Vol. 13, No. 9, 849 - 850.

361. Yun-Song Wang, Hong-Ping He, Yue-Mao Shen, Xin Hong, and Xiao-Jiang Hao. Two New Carbazole Alkaloids from Murraya koenigii. Journal of Natural Products 2003, 66 (3), 416-418

362. Indian Institute of Spice Research (www.iisr.org/spices/curryleaves.html")

329

Bibliography

363. Gopalan C, Rama sastri BV and Balasubramanian SC. In Nutritive Value of Indian Foods, revised and updated by Narasinghrao BS, Devosthale YG and Pant KC. National Institute of Nutrition ICMR Hyderabad, India. 2000

364. Dutt S. The Indian curry leaf tree M.koenigii spreng & it's essential oil. Indian soap Journal 1958 , 23:

201.

365. Nigam, Purohit et al. A Chemical examination of essential oils derived from leaves of Murraya Koenigii. Perfume and Essent oil research 1961b, 52:643.

366. Chowdhary AR. Essential oil from the leaves of Murraya koenigii, NationalSeminar Research and Development in Aromatic Plants: Current trends in biology,uses, production and marketing of essential oils, Lucknow, Central Institute ofMedicinal and Aromatic Plants, 1999

367.Chowdhary JJ., Bhuiyan MNL, Yusuf M. Chemical composition of the leaf essential oils of Murraya Koenigii(L.) spreng and Murraya paniculata(L.). Bangladesh Journal of Pharmacology 2008,3:59-63.

368.33 Palaniswamy UR, Stuart JD, and Caporuscio CA. Effect of Storage temperature on the Nutritional Value of Curry Leaf. Trends in new crops and new uses 2002 , 567-569

369. Charckraborty DP., Bormon BK and Bose PK On the structure of girinimbine a Pyranocarbazole derivatives isoloted from Murraya Koenigii( letters to editor ) Science and culture 1964, 30: 445.

370. Chackrobarty DP, Barman BK and Bose PK. On constitution of murrayanine a. carbazole derivate isolated from Murraya Koenigii. Tetrohedron 1965 , 21: 681

371. Charckraborty DP , Das KC , Bose PK. Structure of mahanimbine, a pryanocarbazole derivative from Murraya Koenigii. Science and culture 1966 , 32,33.

372. Charckraborty DP Islam A Das R 1971 structure of murrayacine Journal of organic Chemistry 1971, 725 .

373. Bhattacharya.P. Chakraborty DP. Mukanol A Probable Biogenetic Intermediate Of Pyranocarbazole Alkaloid. Phytochemistry 1982, 21: 471.

374. Chackroborty DP, Islam A , Basak SP and Das R. Structure of murrayazolidine The first pentacylic carbazole alkaloid chemical Index,No - 18,1970, 593.

375. Chackroborty DP. Bhattacharya L. structure of murrayacinine a new cabazole alkaloid from Murraya Koenigii chemical Index no 4,1974 b, 165.

376. Bhattacharya L, Roy SK. and Chakraborty DP. Structure of carbazole alkaloid isomurrayazoline from Murraya koenigii. Phytochemistry 1982 ,21: 2432.

377. Dutta NL, Quasim C, Wadia MS. Constituents of Murraya Koenigi structure of Curryangin. Indian Journal ofchemistrty 1969,7: 1061

378. Chackroborty DP. .Bhattachrya P. and Mitra, AR. chemical Index No 6,1974,260.

379. Kurrel SP., Kapil, RS. and Popli SP. Terpenoid alksloids from Murraya Koenigii spreng II Constitution of cyclomahanimbine.bicyclomahanimbine and mahanimbidine Tetrahedron lett No.44,1969 3857.

380. Narsimhan NS. and Kelkar SL. Alkaloids of Murraya koenigii: Part Ill-Structures of Curryanine and Curryangine, Indian Journal of chemistry, Voll4B1976 p430-433

381. Chowdhary BK. and Chakraborty DP. Mukoenic acid , the first carbazole carboxylic acid from plant source. Phytochemistry 197la, 10: 1967.

330

Bibliography

382. Chackroborty DP, Bhattacharya P ,Roy S.,Bhttachatya, SP. and Biswas,AK. Structure and synthesis of mukonine, a new carbazole alkaloid from Murraya Koenigii. Phytochemistryl97i, 17 : 834. 50

383. Johannes reisch, Olavgo and Anura wickramasinghe. Bandara Herath and Gerald Henkel P. Carbazole alkaloids from seeds of Murraya koenigii. Phytochemistry 1992, Vol. 31 ,No.-8,2877-2879.

384. Adeleke C Adebajo Johannes Reish Minor furocoumarins of Murraya Koenigii Fitoterapia 2000, 71: 334-337.

385. Roy S, Ghosh S. and Chakraborty DP. Stucture of mahanomboline Chemical Index No. 14,1979,669.

386. Roy S.,Bhattacharya L. and Chakroborty DP. Structure and Synthesis of mukoline and mukolidine : two new carbazole alkaloids from Murraya Koenigii spreng Journal of Indian Chemical Society 1982, 59: 1369

387. Javed Intekhab and Mohammad Aslam Isolation of an alkaloid from the roots of Murraya koenigii Journal of. Saudi Chemical Society 2008, Vol. 12, No. 4: 515-518.

i i i 388. Mohd Aspollah Sukari, Kartini Ahmad , Md Jelas Haron and Radzali Muse Carbazole Alkaloids from Roots ofMurraya Koenigii (RutacQae:)Ma\aysiaa Journal of Analytical Sciences 2001, Vol. 7,No. 1 : 263-265.

389.Furukawa H., Wu TS., Ohta T. and. Kuoh CS. Chemical Constituents of Murraya euchrestifolia Hayata : Structures of Novel Carbazolequinones and Other New Carbazole Alkaloids. Chemical and Pharmaceutical Bulletin 1985, 33(4) : 4132-4138.

390. Khan BA , Abraham A., Lellamma S. Biochemical response in rats to addition of Murraya Koenigii and Brassicajuncea to the diet. Plant foods for Human Nutrition 1996,49(4): 295- 299.

391. Iyer UM. and Mani UV. A study on the effect of curry leaves supplementation on lipid profile glycated protein and amino acid in non insulin dependent patients. Plant foods for Human Nutrition 1990,40 (4): 275.

392. Malmuthuge NSP, Vidanarachchi JK,. Himali SMC, Sivakanesan R. and Cyril HW Effect of Curry Leaf (Murraya koenigii) in Beef Sausage on Blood Cholesterol Level of Mice, Proceedings of the Peradeniya University Research Sessions, Sri Lanka, Vol.12, Part I, 30thNovember 2007.

393. Vinuthan MK., Girishkumar V.,Narayanswamy, M. and Veena T., Lipid lowering effect of aqueous extract of Murraya Koenigii (Curryleaf) on alloxan -induced diabetic rats. Pharmacognosy Magazine 2007, Vol 3, Issue 10:112-115

394. Lawal HA.,Atiku MK.,Khelpai DG and Wannang NN. Hypoglycemic and Hypolipidemic effectof Aqueous leaf extract of Murrraya Koenigii in normal and Alloxan diabetic rats. Neigerian Journal of Physiological science 2008, 23 (1-2): 37-40

395..Dixit VK. and Sharma AK. Hypolipidemic activity of MurrayaKoenigii in rats. Indian drugs May 2008, 45 (5): 401-406

396.. Parab RS, and Mengi AS. Hypolipidemic activity of Acorus calamus in rats Fitoterpia 2002, 73:451- 55.

397. Xie Jing-Tan, Chang Wei-tien Chig -zhi, Mehendale S.R., Li Jing , Ambihaipahar Ramalingam, Ambihaipahar Umadevi, Fong Harry H, Yuan Chun-Su,Curry leaf (Murraya KoenigiiSpreng) reduces blood cholesterol and glucose levels in ob/ob mice,The American Journal of Chinese Medicine 2006,34 (2): 279-84.

398. Rahul Birari, Vishal Javia, Kamlesh Kumar Bhutani. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia 2010,Vol: 81, Issue :8: 1129-1133.

331

Bibliography

399. S. Yadav, V. Vats, Y. Dhunnoo, J.K. Graver Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats Journal ofEthnopharmacology 2002, 82:111-116

400. Achyut Narayan Kesari, Rajesh Kumar Gupta, Geeta Watal Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits Journal ofEthnopharmacology 2005,97: 247-251.

401. Arulselvon GP., Senthikumar D.,Satish kumar and Subramanian S. Antidiabetic effect of Murraya Koenigii leaves on streptozocine induced diabetic rats, Pharmazine 2006, 61(10): 874-877.

402. Arulselvon P. Subramanian S. Effect of Murraya Koenigii leaves on carbohydrate Metabolism studied in streptozocine induced diabetic rats, International Journal of Biological chemistry 2007, l(l):21-28.

403.Vinuthan MK.,Girish Kumar V, Ravindra J.P. Jayaprakash and Narayana K.,Effect of Murraya Konigii leaves on the levels of blood glucose and plasma insulin in alloxan induced diabetic rats. Indian Journal of physiology and pharmacology 2004,48 (3): 348-352.

404. Mahantayyaa VM. and Balsubramaniam P.,Hypolycemic effct of curry leaves. Indian Journal of physiology and pharmacology 2005,49(2): 241-42.

405. Khan BA, Abraham A, Leelamma S. Hypoglycemic action of Murraya Koenigii (curry leaf) and Brassica juncea (mustard): mechanism of action. Indian Journal of Biochemistry and Biophysics 1995, 32: 106-108.

406. Menakshi Bhat, Smita S. Zinjarde, Shobha Y. Bhargava, Ameeta Ravi Kumar and Bimba N. Joshi, Antidiabetic Indian Plants: a Good Source of PotentAmylase Inhibitors eCAM Advance Access June 2008, 27: 1-6.

407..S.K. Prasad, Alka Kulshreshtha and Taj N. Qureshi, Antidiabetic Activity of Some Herbal Plants in Streptozotocinlnduced Diabetic Albino Rats. Pakistan Journal of Nutrition 2009, 8 (5): 551-557.

408. Jain S., Pandhi P., Singh AP, Malhotra S. Efficacy of standardized herbal extracts in typel diabetes-An experimental study. African Journal of Traditional, Complementary and Alternative Medicines 2006, Vol. 3, No. 4: 23-33.

409. Adebajo AC, Olayiwola, G., Verspohl JE.Jwalewa EO., Onisore, NA., Bergentbal,D., Kumar, V. and Adesina, SK. Evaluation of the ethnomedical claims of M.koenigii. Pharmaceutical Biology 2004,42(8): 610.

410. Narendhirakannan RT, Subramanian S, Kandaswamy M.Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats. Clinical and Experimental Pharmacology and Physiology 2006, Dec33 (12):1150-57.

411. Pande MS., Gupta S. P. B.N , Pathak A. Hepatoprotective activity of Murraya Koenigii Linn bark. Journal of Herbal Medicine and Toxicology 2009, 3 (1): 69-71.

412. Gambhire, MN., Juvekar, AR. Sakat SS.Evaluation of anti-inflammatory activity of methanol extract of murraya koenigiin leaves by in vivo and in vitro methods, Pharmacology onlinelW), 1:1072-1094.

413. Shah.AS.,WakadeA.S.,Juvekar A.R.Immunomodulatory activity of methanolic extract of Murraya Koenigii(L) Spreng. Leaves , Indian journal of Experimental Biology 2008, Vol 46 :505—509.

414. Khan BA, Abraham A and Leelamma S, 'Antioxidant effects of curry leaf Murrayakoenigii and mustard seeds Brassica juncea in rats fed with high fat diet', Indian Journal of Experimental Biology 1997, 35 (2) 148— 50.

415. Arulselvan Palanisamy, Pillai S.S. Beneficial fffects of Murraya Koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic beta cells in experimental diabetes in rats , Chemico-Biological interactions 2007, 165 (2): 155-64.

332

Bibliography

416. Arulselvan P.and Subramanian S.,Ultrastructural and Biochemical abnormalities in the liver of Streptozocine- Diabetic rats :Protective effects of Murraya Koenigii. Journal of pharmacology and Toxicology 2008, 3(3): 190-202,2008

417. Gupta RS. and Singh D. Protective nature of Murray>a Koenigii Leaves against Hepatosupression through antioxidant status in experimental rats. Pharmacologyonline 2007,1:232-242.

418. Khan BA., Abraham A. and Leelamma S., Role of Murraya koenigii(Curry leaf) and Brassica Juncea (Mustard) in lipid Peroxidation. Indian Journal of Physiology and Pharmacology 1996,40(2): 155-158.

419. Patel RS and Rajorhia. Antioxidative role of curry (Murraya koenigii) and betal (Piper betle) leaves in goes., Journal of Food Science and Technology 1979,16 (4): 158-60.

420. Yukari Tachibana,, Hiroe Kikuzaki,, Nordin Hj. Lajis,, and Nobuji Nakatani, Antioxidative Activity of Carbazoles from Murraya koenigii Leaves, Journal of Agricultural and Food Chemistry 2001, 49 (11): 5589-5594.

421. Huda-Faujan, N., Noriham, A., Norrakiah, A. S. and Babji, A. S. Antioxidant activity of plants methanolic extractscontaining phenolic compounds, African Journal of Biotechnology 4 February 2009,Vol. 8 (3), 484-489.

422. Rao LJM., Ramalakshmi K., Borse BB., Raghavan B. Antioxidant and radical-scavenging carbazole alkaloids from the oleoresin of curry leaf (Murraya koenigii Spreng.) Food Chemistry 2007,100 :742-747.

423. Vasudevan M.,Parle M.,Sengottuvelu S.Shanmugapriya T. Nootropic potential of Murraya Koenigii leaves in rats. Oriental pharmacy and Experimental Medicine,200S 8(4),365-373.

424. Kumar NS., Mukherjee PK., Bhadra S., Saha BP, Pal BC. Acetylcholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii. Phytotherapy Research, 2010,24(4), 629-631.

425. Goutam MP. and Purohit RM. Animicrobial activity of essential oil of the leaves of Murraya Koenigii (Linn)Spreng.( Indian curry leaf) Indian Journal of pharmacy 1974,36:11

426. Das K. C , Chakraborty D. P. & Bose P. K. Antifungal activity of some constituents of Murraya koenigii Spreng. Experentia 1965; 21: 340.

427. Vaijayantimala, Anandi C , Udhaya V.,. Pugalendi KV. Anticandidial activity of certain Indian Medicinal plants Phytoterapy research May 2000, Volume 14 issue 3: 207-209.

428. Lee Seong Wei, Najiah Musa, Chuah Tse Sengm, Wendy Wee and Noor Azhar Mohd Shazili, Antimicrobial properties of tropical plants against 12pathogenic bacteria isolated from aquatic organisms, African Journal of Biotechnology July, 2008, Vol. 7(13): 2275-2278.

429. Gupta S., Paarakh PM. and Gavani U., Antibacterial Activity of Murraya koenigii Linn Leaves, Pharmacologyonline 2009, 1: 270-275.

430.. Ningappa MB., Dhananjaya BL., Dinesha R., Harsha R., Srinivas L. Potent antibacterial property of APC protein from curry leaves (Murraya koenigii L., Food Chemistry 2010, 118 :747-750

431. Singh R,and Singh R. serening of some plant extracts for antiviral properties. Technology 1972 , Sindri 9: 415.

432. Rajadurai M., Vidhya VG., Ramya M. and Bhaskar A., Ethno-medicinal Plants Used by the Traditional Healers of Pachamalai Hills, Tamilnadu, India, Ethno-Medicine 2009, 3(1): 39-41.

333

Bibliography

433. Mandal S., Nayak A , Kar M., Banerjee S K, Das A., Upadhyay SN, Singh RK., Banerji A., Banerji J. Antidiarrhoeal activity of carbazole alkaloids from Murraya koenigii Spreng (Rutaceae) seeds. Fitoterapia 2010 ,81:72-74.

434.100.96. Math MV and Balasubramaniam P. Curry lea\es(Murraya Koenigii spreng) and halitosis. British MedicalJourtnal SouthAsia 2003;19(3):211

435. Math MV. and Balasubramaniam P ..Curry leaves. British Dental Journal 2004,197: 519.

436. Purwal L., Gupta SPBN and Pande MS., Development and Evaluation of Herbal Formulations for Hair Growth, E-Journalof chemistry 2008,Vol. 5, No. 1: 34-38.

437. Malwal. M., Sarin R. , Shakeet P., Bakshi S. Natural insect controlling agents from Murrayakoenigii (1.) spreng. Journal of Herbal Medicine and Toxicology 2009, 3 (1): 161-162.

438. Shukla R., Srivastava, B., Kumar, R. and Dubey, NK. Potential of some botanical powders in reducing infestation of chickpea by Callosobruchus chinensis L. (Coleoptera :Bruchidae). Journal of Agricultural Technology 2007,3 (1): 11-19.

439. Peta D. and Pathipati UR., Biological potency of certain plant extracts in management oftwo lepidopteran pests of Ricinus communis L., Journal of Biopesticides 2008 ,1(2):170 - 176.

440. Pathak N., Yadav TD. and Vasudevan P. Contact and fumigant action of volatile essential oil of Murraya koenigii against C. chinensis. Indian Journal of. Enetrology 1997, 59 (2): 198-202.

441. Dwivedi SC. and Venugopalan S., Evaluation of Leaf Extracts for their Ovicidal Action Against Callosobruchus chinensis (L.), Asian Journal of. Exprimental. Sciences 2001, Vol. 16, No. 1&2: 29-34.

442. Gahloth D., Shee C, Islam A., Ahmadb F.and Sharma AK. Structure- Function studies of Murraya koenigii trypsin inhibitor revealed a stable core beta sheet structure surrounde by alpha helices with aposiblerole foe alpha helix in inhibitory function. International Journal of Biological Macromolecules 2007; 41(4): 410-4.

443. Narasimhan, NS.; Paradkar, MV.; Chitguppi, VP. Structures of mahanimbine and koenimbine. Tetrahedron Letter. 1968,5 : 5501-5504.

444. Ito, Itoigawa M., Nakao K., Murata T., Tsuboi M., Kaneda N., Furukawa H. Induction of apoptosis by carbazole alkaloids isolated from Murraya koenigii. Phytomedicine 2006, 13: 359-365.

445. Bhattacharyaa K., Samanta SK, Tripathi R.,.Mallick A., Sarmila C.Bikas C. Pal C, Shaha C, Mandal C, Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways Biochemical Pharmacology 2010 , 79: 361-372

446. Satyavati GV.,.Gupta AK. and Tandon N. Ocimum sanctum Linn. Medicinal plants of India in : Cultivation and Utilization of medicinal Plants, Atal, CK. and .Kapoor BM.(Eds).Vol-2.

447. Sirkar NN. Pharmacological basis of Ayurvedic therapeutics. In: Cultivation and utilization of medicinal plants. Editors: Atal CK and Kapoor BM (Published by PID CSIR) 1989.

448. Wealth of India Vol-VII, 1966 p 87-89.

449. Ayurvedic Pharmacoepia of India Part I Vol II First edition p 162-167]

450. Nair AG H., Gunasegaran R., Joshi, BS. Indian Journal of Chemistry 1982, 21B, 979—980.

451. Laakso, I., Sepphnen-Laakso, T., Hermann-Wolt, B., Kuhnel, N., Knobloch, K. Planta Medica 1990, 56: 527.

334

Bibliography

452. Lai RN., Sen TK., Nigam C. Gas Chromatography of essential oil of O.Sanctum Parfiimerie und Kosmetiks, 1978,59:230-231

453.. Day BB Chaudhary MA. Essential oil of Ocimum sanctumLinnae and its antimicrobial activity. Indian Perfume 1984,28:82.

454. Skaltsa H. ,Tzakou O and loukis A. Analysis of the essential oil of ocimum-sanctum L Plantes Medicinales etPhytotherapiae 1988, 22(4): 280-282.

455. Skalta M. .Couladi M., Philianos S. and Singh M. Phytochemical study of the leaves of ocimum-sanctum. Fititerapiaim, 58 (4): 286.

456. Hakkim FL, Gowri Shankar C. and Girija S. Chemical Composition and antioxidant Property of Holy Basil (Ocimum sanctum L.) Leaves, Stems, and Inflorescence and their in Vitro Callus Cultures. Journal of Agriculture andFood Chemistry 2007, 55 (22): 9109-9117.

457. Supawan B. ,Chanida P., Nijsiri R. Chemical composition and antioxidative properties of essential oils from four Ocimum species endemic to Thialand. Journal of Health research 2007,21(3) :201-206.

458. Chemical abstracts 195448 :11728.

459. No"rr H., Wagner H. New constituents from Ocimum sanctum. Planta Medica 1992, 58: 574.

460. Anonymous Wealth of India.Publication and Information Directorate, CSIR, New Delhi. 1991; Vol. 7, p. 79-89.

461. Sekhawat PS, Prasada R. Antifungal properties of some plant extracts. II growth inhibition studies. Science Culture 1971; 37:4(M1.

462. Rao BG, Nigam SS. The in vitro antimicrobial efficiency of essential oils. Indian Journal of Medical Research 1970; 58: 627-633.

463. Day BB., Choudhury MA. Essential oil of Ocimum sanctum L. and its antimicrobial activity. Indian Perfumer 1984 ; 28(2): 82-87.

464. Prasad G, Kumar A, Singh AK, Bhattacharya AK, Singh K, Sharma VD. Antimicrobial activity of essential oils of some Ocimum spp. and clove oil. Fitoterapia 1986; LVII: 429-432.

465. Phadke SA, Kulkurni SD. Screening of in-vitro antibacterial activity of Teminalia chebula, Eclapta alba and Ocimum sanctum. Indian Journal of Medical Sciences 1989; 43: 113-117.

466. Sinha GK, Gulati BC. Antimicrobial and antifungal study of some essential oils and their constituents. Indian Perfumer 1990 ; 34: 126-129.

467. Geeta Vasudevan DM , Kedlaya R, Deepa S, Ballal M. Activity of Ocimum sanctum (the traditional Indian medicinal plant against the enteric bacteria. Indian Journal of Medical Science 2001; 55:534-538.

468. Singh S, Malhotra M, Majumdar DK. Antibacterial activity of Ocimum sanctum L.fixed oil. Indian Journal of ExprimentalBiology 2005; 43: 835-837.

469. Shokeen P, Ray K, Bala M, Tandon V. Preliminary studies on activity of Ocimum sanctum, Drynaria quercifolia and Annona squamosa against Neisseria gonorrhoeae. Sexually Transmitted Diseases 2005; 32(2): 106-111.

470. Shokeen P, Bala M, Singh M, Tandon V. In vitro activity of eugenol, an active component from Ocimum sanctum, against multiresistant and susceptible strains of Neisseria gonorrhoeae. International Journal of Antimicrobial Agents 2008; 32: 174-179.

335

Bibliography

471. Aqil F, Khan MSA, Owais M, Ahmad I. Effect of certain bioactive plant extracts on clinical isolates of P-lactamase producing methicillin resistant Staphylococcus aureus. Journal of Basic Microbiology 2005; 45: 106— 114.

472. Viyoch J, Pisutthanan N, Faikreua A, Nupangta K, Wangtorpol K, Ngokkuen J. Evaluation of in vitro antimicrobial activity of Thai basil oils and their micro-emulsion formulas against Propionibacterium acnes. International Journal of Cosmetic Science 2006;28: 125-133.

473. Mondal S, Mirdha BR, Naik SN, Mahapatra SC. Antimicrobial activities of essential oils obtained from fresh and dried leaves of Ocimum sanctum (L) against enteric bacteria and yeast. Eds ,AK Yadav. Proceedings of International Symposium on Medicinal and Nutraceutical Plants. Acta Horticulturae 2007; 756: 267-269.

474. Ocimum sanctum. The Indian home remedy. In: Current Medical Sciene, March-April 1992 .Edited and published by S. Rajeshwari, Cipla Ltd., Bombay Central, Bombay.

475. Pandey BP, Anita. In Economic Botany, Published by Chand and Company Ltd., Ramnagar,New Delhi, p. 294,1990

476. Sarkar A, Pandey DN, Pant MC. A report on the effects of Ocimum sanctum (Tulsi) leaves and seeds on blood and urinary uric acid, urea and urine volume in normal albino rabbits. Indian Journal of Physiology and Pharmacology 1990; 34: 61-62.

477. Giri J, Suganthi B, Meera G. Effect of Tulasi {Ocimum sanctum) on diabetes mellitus. Indian Journal of Nutrtion andDietetics 1987; 24: 193-198.

478. Chattopadhyay RR. Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats. Indian Journal of Experimental Biology 1993 ; 31: 891-893.

479. Rai V, Iyer U, Mani UV. Effect of Tulasi {Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissue lipids in diabetic rats. Plant Foods for Human Nutrition 1997; 50: 9-16.

480. Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alteration in glycogen content and carbohydrate metabolism in rats. Journal of Ethanopharmacology 2004; 90: 155-160.

481. Gupta S, Mediratta PK, Singh S, Sharma KK, Shukla R. Antidiabetic, antihypocholestrolaemic and antioxidant effect of Ocimum sanctum (Linn) seed oil. Indian Journal of Experimental Biology 2006; 44: 300-304.

482. Chandra A, Mahdi AA, Singh RK, Mahdi F,Chander R. Effect of Indian herbal hypoglycaemic agents on antioxidant capacity and trace elements content in diabetic rats. Journal of Medicinal Food 2008; 11: 506-512.

483. Reddy SS, Karuna R, Baskar R, Saralakumari D. Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose fed rats. Hormone and Metabolic Research 2008; 40: 44-^49.

484. Hannan JMA, Marenah L, Alii L, Rokeyal B, Flatt PR, Abdel-Wahab YHA. Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic beta-cells. Journal of endocrinology 2006; 189:127-136.

485. Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trail of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmcology and Therpeutics 1996;34:406-409.

486. Rai V, Ficn U, Mani V, Iyer UM. Effect of Ocimum sanctum leaf powder on blood lipoproteins, glycated proteins and total amino acids in patients with non-insulin dependent diabetes-mellitus. Journal of Nutritional and Environmental Medicines 1997; 7:113-118.

336

Bibliography

487. Godhwani S, Godhwani JL , Vyas DS. Ocimum sanctum: an experimental study evaluating its anti­inflammatory, analgesic and antipyretic activity in animals. Journal of Ethnopharmacology 1987; 21:153-163.

488. Singh S, Agrawal SS. Anti-asthematic and antiinflammatory activity of Ocimum sanctum Lin. Journal of Reearch and Education in Indian Medicines 1991; 7-9: 23-28.

489. Singh S, Majumdar DK, Rehan HMS.Evaluation of anti-inflammatory potential of fixed oil of Ocimum sanctum (holy basil)and its possible mechanism of action. Journal of Ethnopharmacology 1996; 54: 19-26.

490. Singh S, Majumdar DK. Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil. Indian Journal of Experimental Biology 1997; 35:380-383.

491. Singh S, Nair V, Jain S, Gupta YK. Evaluation of anti-inflammatory activity of plant lipids containing alpha-linolenic acid. Indian Journal of Experimental Biology 2008; 46(6): 453-456.

492. Juntachote T, Berghofer E, Antioxidative properties and stability of ethanolic extracts of Ocimum sanctum. Food Chemistry 2005, 92:193-202]

493. S.U. Yanpallewar, Sunita Rai, Mohan Kumar, S.B. Acharya Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacology, Biochemistry and Behavior 2004, 79 :155-164.

494. James Samson, Rathinasamy Sheeladevi, Rajan Ravindran Oxidative stress in brain and antioxidant activity of Ocimum sanctum in noise exposure. NeuroToxicology 2007,28: 679-685.

495. Godhwani S, Godhwani JL, Vyas DS. Ocimum sanctum - a preliminary study evaluating its immunoregulatory profile in albino rats. Journal of Ethanopharmacology 1988; 24: 193-198.

496. Mediratta PK, Devan V, Bhattacharya SK, Gupta PC, Maiti PC, Sen P. Effect of Ocimum sanctum Linn, on humoral immune response. Indian Journal of Medical Research 1988; 87: 384-386.

497. Mediratta PK, Sharma KK, Singh S. Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action. Journal of Ethnopharmacology 2002; 80: 15-20.

498. Mukherjee R, Dash PK, Ram GC. Immunotherapeutic potential of Ocimum sanctum (L) in bovine sub clinical mastitis. Research in Veterinary Science 2005; 79: 37—43.

499. Singh S, Majumdar DK, Singh JP. Studies of therapeutic efficacy of fixed oil of Ocimum sanctum in bovine mastitis. Indian Veterinary Journal 1995; 72: 867-869.

500. Delini-Stula, A., Radeke, E. and Riezen, Van H. Enhanced functional responsiveness of the dopaminergic system. The mechanism of antiimmobility effects of antidepressants in the behavioural despair test in the rat. Neuropharmacology 1988, 27: 943-974.

501. Gilman AG, Goodman LS, Rail, TW and Murad F. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed., 1985, Macmillan Publishing Co., New York, pp. 482-483.

502. Sakina MR, Dandiya PC, Hamdard ME and Hameed A. Preliminary psychopharmacological evaluation of ocimum sanctum leaf extract, Journal of Ethnopharmacology, 28 (1990) 143-150.

503. Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D. Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats Journal of Ethno pharmacology 2008,120 : 56-62.

504. Sembulingama, K, Sembulingama P, Namasivayamb A. Effect of Ocimum sanctum Linn on the changes in central cholinergic system induced by acute noise stress Journal of Ethnopharmacology 2005, 96 : 477-482.

337

Bibliography

505. Samson J, Sheela Devi R, Ravindran R, Senthilvelan M. Biogenic amine changes in brain regions and attenuating action of Ocimum sanctumin noise exposure. Pharmacology, Biochemistry and Behavior 2006, 83:67-75.

506. Sethi J, Sood S, Seth S, Talwar A. Proactive effect of {Ocimum sanctum) on lipid peroxidation in stress induced by anaemic hypoxia in rabbits. Indian Journal of Physiology and Pharmacology 2003; 47: 115-119.

507. Singh N, Mishra N, Srivastava AK, Dixit KS.Gupta GP. Effect of anti stress plants on biochemical changes during stress reaction. Indian Journal ofPharmac ology 1991; 23: 137-142.

508. Geeta KR, Vasudevan DM. Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: in vivo and in vitro studies. Life Sciences 2004; 76: 21-28.

509. Ravindran R, Rathinasamy SD, Samson J, Senthivelan M. Noise stress induced brain neurotransmitter changes and the effect ofOcimum sanctum (Linn) treatment in albino rats. Journal of Pharmacological Sciences 2005; 98: 354-360.

510. Sebulingam K, Sebulingam P, Namasivayam A.Effects of Ocimum sanctum lin on noise induced changes in the plasma corticosterone level. Indian Journal of Physiology and Pharmacology 1997; 41: 139-143.

511. Maity TK, Mandal SC, Saha BP, Pal M. Effect of Ocimum sanctum root extract on swimming performance in mice. Phytotheapy Research 2000; 14: 120-121.

512. Maity TK, Dinda SC, Pal M. Studies on some psychopharmacological activities of Ocimum sanctum root extract. Indian Journal oj Traditional Knowledge2003; 2: 284-288.

513. Bhattacharya SK, Bhattacharya A, Das K, Muruganandam AV, Sairam K. Further investigations on antioxidant activity of Ocimum sanctum using different paradigms of oxidative stress in rats. Journal of Natural Remedies 2001; 1:6-16.

514. Sen P, Maiti PC, Puri S, Ray A. Mechanism of anti-stress activity of Ocimum sanctum Lin.,eugenol and Tinospora malabarica in experimental animals. Indian Journal of Experimental Biology 1992;30: 592-596.

515. Aruna K, Sivaramakrishnan VM. Anticarcinogenic effects of some Indian plant products. Food and Chemical Toxicology 1992 ; 30: 953-956.

516. Serrame E, Lim-Sylianco CY. Anti-tumor promoting activity of decoctions and expressed juices from Phillipine medicinal plants. Philippine Journal of Science 1995; 124: 275-281.

517. Banerjee S, Prashar R, Kumar A, Rao AR. Modulatory influence of alcoholic extract of

Ocimum leaves on carcinogen-induced metabolizing enzyme activities and reduced glutathione levels in mouse. Nutrition and Cancer 1996; 25: 205-217.

518. Devi PU, Ganasoundari A. Radioprotective effect of leaf extract of Indian medicinal plant Ocimum sanctum. Indian Journal of Experimental Biology 1995; 33: 205-208.

519.. Ganasoundari A, Zare SM, Uma Devi P. Modification of bone marrow radio-sensitivity by medicinal plant extracts. British Journal of Radiology 1997;70: 599-602.

520. Uma Devi P, Bisht KS, Vinitha MA Comparative study of radioprotection by Ocimum flavonoids and synthetic aminothiol protectors in the mouse. British Journal of Radiology 1998; 71: 782-784.

521. Ganasoundari A, Devi PU, Rao BSS.Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum. Mutation Research 1998; 397: 303-312.

338

Bibliography

522. Devi PU, Ganasoundari A. Modulation of glutathione and antioxidant enzymes by Ocimum sanctum and its role in protection against radiation injury. Indian Journal of Experimental Biology 1999; 37:262-268.

523. Devi PU, Ganasoundari A, Vrinda B.Srinivasan KK, Unnikrishnan MK. Radiation

protection by the Ocimum flavonoids orientin and vicenin: mechanisms of action. Radiation Research 2000; 154: 455-460).

524. Kasinathan S, Ramakrishnan S, Basu SL. Antifertility effect of Ocimum sanctum L. Indian Journal of Experimental Biology 1972; 10: 23-25.

525. Seth SD, John N, Sundaram KR. Anti-spermic effect of Ocimum sanctum. Indian Journal of Experimental Biology 1981; 19: 975-976.

526. Khanna S, Gupta SK, Grover JK. Effect of long term feeding of Tulsi (Ocimum sanctum L) on reproductive performance of adult albino tatsJndian Journal of Experimental biology 1986; 24: 302-304.

527. Kantak SM, Gogate MG. Effect of short-term administration of Tulsi (Ocimum sanctum) on reproductive behavior of adult male rats. Indian Journal of Physiology and Pharmacology 1992; 36: 109-111.

528. Singh S, Majumdar DK. Toxicological studies of the fixed oil of Ocimum sanctum Linn. (Tulsi). New Botanist 1994; 21: 139-146.

529. CPCSEA guidelines for laboratory animal facility. Committee for the purpose of control and supervision of experiments on animals. Indian Journal of Pharmacology. 2003,;35: 257-74.

530. The Ayurvedic pharmacopeia of India Part - I vol II First edition 1999, pl90-191.

531. Indian Herbal Pharmacopoeia, Vol I, By regional research laboratory, Jammu-Tawi and Indian Drug Manufacturers association (Mumbai), Published by Regional Research Laboratory, Jammu-Tawi and Indian Drug Manufacturers Association, 1998 p 87.

532. Kokate C.K. In "Analytical Pharmacognosy" 17th Ed, Nirali Prakashan, Pune,, 2001, p 106-109.

533.Lazarowych L and Pekos P Use of Fingerprinting and marker compounds for identification and standardization of botanical drugs: strategies for applying pharmaceutical HPTLC analysis to herbal products". Drug Information Journal, 1998; 32: 497-512.

534.Thomas E, Beesley, B Benjamin, RPW. Scott. Quantitative chromatographic Analysis by Marcel Dekker Inc, Published by library of Congress Cataloging in Publication data, New York, Basel, chapter 10, TLC Apparatus, 2001 p 9-10, 324-330.

535. Blois MS. Antioxidant determinations by the use of stable free radical. Nature, 1958; 181: 1199-1200.

536. Sreejayan and Rao MN. Nitric oxide scavenging by curcuminoids. Journal of Pharmacy and Pharmacology 1997; 49:105-107.

537. Ecobichon DJ The Basis of Toxicology Testing. CRC Press New York, 1997; p 43-86. 538 Ghosh M.N. In toxicity studies Fundamentals of Experimental pharmacology, 2nd edition scientific book agency Calcutta ,(1984), p 153-158.

539. Paget GE. and Barnes JM. Toxicity tests. In Evaluation of Drug Activity: Pharmacometrics (eds Lawrence, D.R. and Bacharach, A.L.), Academic Press, London. 1964, 140-161.

540.The Ayurvedic Pharmacopeia of India Part - I Vol-VI, first edition Government of India (AYUSH) ,The controller publication, First edition 2004, p 145-147

339

Bibliography

541. Indian Herbal Pharmacoepia Vol II, Ajanta Publicationsof regional research and Indian drug Manufacturer's association, 1999,77-84

542. Turner RA. Depression of central nervous system in Screening methods in pharmacology New york :academic press,1965, 78

543. Pellow S, Chopin P., File SE and Briley M Validation of open closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal ofneuroscience methods 1985 , 14: 149-67.

544. File SE. Wardil AG, Validity of head-dipping as a measure of exploration in a modified hole-board. psychopharmacology 1975,44:53-59.

545. Porsolt RD., Anton G., Blavet N., Jalfre M. Behavioural Despair: A new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978,47: 379-391.

546.Steru L Chermat R Thierry B Mico J.A. Lenegre A. Stem M Simpon P. The automated tail suspension test: A computerized device which differentiates psychotropic drug, Progress in. Neuropsychopharmacology biological. Psychiatry 1987,11 :659-671.

547.Kamakura M., Mitani N., Fukuda T., Fukushima M. Antifatigue effect of fresh Royal jelly in mice. Journal of Nutritional Science and Vitaminology 2001,47, 394-401.

548. Matsumoto K., Ishihara K., Tanaka K., Inoue K., Fushiki T. An adjustable-current swimming pool for the evaluation of endurance capacity of mice. Journal of Applied Physiology 1996,81: 1843-1849.

549.Bostrom S., Fahlen M., Hjalmarson A., Johansson R., Activities of rat muscle enzymes after acute exercise. Acta Physiologica Scandinavia 1974,90: 544-554.

550. Kamakura, M., Mitani, N., Fukuda, T., Fukushima, M. Antifatigue effect of fresh Royal jelly in mice. Journal of Nutritional Science and Vitaminology 2001,47: 394-401.

551. Doreen Beattie. Physiological changes in rats exposed to cold restraint stress Life Sciences 1978,Vol. 23: 2307-2314.

552.Senay EC, Levine RJ. Synergism between cold and restraint for rapid production of stress ulcers in rats. Proceeding of Society of Experimental Biology Medicine 1967,124: 1221-1223.

553.Soman I. Mengi SA. Kasture SB. Effect of leaves of Butea frondosa on stress, anxiety, and cognition in rats. Pharmacology, Biochemistry and Behavior 2004, 79 : 11-16.

554.Bhattacharya SK and. Bhattacharya D. Effect of restraint stress on rat brain serotonin. Journal ofBioscience September 1982 , Vol. 4, Number 3: 269-274.

555.Itoh J. Nabeshima T. Kameyama TY. Utility of elevated plus maze for the evaluation of memory in mice : Effects of nootropics Scopolamine, electroconvulsive shocks. Psychopharmacology 1990,101:27-34.

556.Jaiswal AK, Bhattacharya SK. Effect of prenatal under nutrition and phenobarbitone administration on discrimination learning and passive avoidance behaviour in rats. Indian Journal of Experimental Biology 1996; 34: 118-23.

557. Armando I, Lemoine AP, Segura ET, Barontini M. The stress-induced reduction in MAO A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors. Cellular and Molecular Neurobiology 1993, 13: 593-600.

558. Porsolt RD. Bertin A. and Jalfre M. Behavioral despair test Archieves internationals de Pharmacodynamine et de therapie 1977,229: 327.

340

Bibliography

559. Murua VS. , Gomez RA, Andrea ME and Molinat VA. Shuttle-Box Deficits Induced by Chronic Variable Stress:Reversal by Imipramine Administration, Pharmacology Biochemistry & Behavior, Vol. 38: 125-130.

560. Medeiros R. Neuroethological differences in sleep deprivation induced by single and multiple platform methods. Brazillian Journal of medical and biological research. May 1998,31(5):675-680.

561. Krugers HJ, Jaarsma D, Korf J. Rat Hippocampal Lactate Efflux During Electroconvulsive Shock or Stress Is Differently Dependent on Entorhinal Cortex and Adrenal Integrity. Journal of Neurochemistry March 1992,Volume 58, Issue 3: 826-830.

562.Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11: 47-60.

563.Tsopanakis C Tesserommatis C Cold Swimming Stress: Effects on Serum Lipids, Lipoproteins and LCATA activity in Male and Female Rats Pharmacology Biochemistry & Behavior. 1991, Vol. 38: 813-816.

564. Erba Diagnostic Mannheim kits leaflets

565. AGAPPE Diagnostic kits leaflets

566.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with me folin phenol reagent The Journal of Biological Chemistry 1951 , Nov;193 (1): 265-75.

567.Carroll NV,. Longley RW, and Joseph HR. The determination of glycogen in liver and muscle by use of anthrone reagent Journal of biological chemistry 1954, Vol 220:583-93.

568. Ciarlone AE. Further modification of a Fluorometric Method for Analyzing Brain Amines Microchemical Journal 1978,23:9-12.

569. Chang CC A sensitive method for spectrophotofluorometric assay of catecholamines. International Journal of neuropharmacology 1964, 3:643-49.

570. Hestrin S The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine and its analytical applications. The Journal of Biological Chemistry 1949,24: 249-261.

571. Augustinsson BK Assay methods for cholinesterases. Methods in Biochemical Analysis 1957, 7: 43-47.

572. Ohkawa H, Yagi K : Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Annals of Biochemistry 1989 , 95: pp 351- 358

573. Patterson BD Ferguson IB. Estimation of hydrogen peroxide using titanium (IV). Annals of biochemistry 1984, 139: 487-492.

574. Ellman George LA Colorimetric Method for Determining Low Concentrations of Mercaptans Archives of biochemistry and biophysics 1958 74,443-459.

575. Bhutani KK. Finger printing of Ayurvedic Drugs, The Eastern pharmacist 2000; 3,21-26.

576.Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, U.S. Department of Health and Human Services ,Food and Drug Administration,Center for Drug Evaluation and Research (CDER),August 1997, p-7

577 Lachman L. Liberman HA. Kanig JL., The theory and Practice of Industrial pharmacy, 3rd Edition , Published by:Varghesee Publishing house, 19990,389-97.

578. United State Pharmacoepia 30, NF 25, "Dissolution" ,Published by :United state Pharmacoepial convention, 2007, Vol.l, 277-279

341

Bibliography

579. Sinco Patric J. Martin's Physical Pharmacy and Pharmaceutical sciences, In chapter Micrometrics^* Editionjhiblished by:Lippincott Williams and Wilkins,Walter house,2011,461-464

580. Lachman L. Liberman HA. Kanig JL., The theory and Practice of Industrial pharmacy, 3rd Edition , Published by:Varghesee Publishing house, 19990, 52.

581.Stability testing of new drug substances and products Q1A(R2) in ICH Harmonised Tripartite Guideline ,Current Step 4 version dated 6 February 2003,3-6

582. Phytochemical method: A guide to modern Tecniques of plant analysis ,3 rd edition By Harborne JB., Springer publication , 2005, p 207.

583.Evans WC. Treas and Evans Pharmacognosy ,15th edition, saunders publication, 139-140

584.Beckett AH. Stenlake JB. Practical pharmaceutical chemistry, Fourth Edition -part Two CBS Publisher and distributors, 2005, p 86.

585. Harborne JB Phytochemical method: A guide to modern Techniques of plant analysis , 3rd edition By., Springer publication, 2005, 207

586. Phytochemical method: A guide to modern Techniques of plant analysis , 3rd edition By Harborne JB., Springer publication, 2005,17-29

587.Harborne JB, Phytochemical Method: A guide to modern techniques of plant analysis^"1 Edition, Springer publication 2005,22.

588. Beckett AH. Stenlake JB. Practical pharmaceutical chemistry, Fourth Edition -part Two CBS Publisher and distributors, 2005, p408.

589. Harborne JB, Phytochemical Method: A guide to modern techniques of plant analysis, 3rd Edition, Springer publication, 2005, p23.

590. Kenjale RD, Shah RK and Sathaye SS. Antistress and antioxidant effects of roots of chlorophytum borivilianum (Santa Pau and Femandes). Indian Journal of experimental biology November 2007, Vol.45:974-979.

591. Petit-Demouliere B. Chenu F. Bourin M Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 2005, 177: 245-255.

592. Steru L. Chermat R. Thierry B. Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85: 367-370.

593. Willner P. The validity of animal models of depression. Psychopharmacology 1984.83: 1-16.

594. Dixon AK. Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. British Journal of Medical psychology ,1998. 71 (Pt 4), 417-445.

595. Gilbert P. , Allan S. The role of defeat and entrapment (arrestedflight) in depression: an exploration of an evolutionary view. Psychological Medicine 1998, 28: 585-598.

596. Weingartner H. , Silberman E. Models of cognitive impairment: cognitive changes in depression. Psychopharmacology Bulletin 1982,18: 27-42.

597. Gavrilovic L. Dronjak S. Activation of rat pituitary-adrenocortical and sympatho-adrenomedullary system in response to different stressors, Neuro Endocrinology Letters 2005, 26: 515-520.

342

Bibliography

598. Michalkiewicz M., Knestaut KM., Bytchkova EY., Michalkiewicz T. Hypotension and reduced catecholamines in neuropeptide Y transgenic rats. Hypertension , 2003,41: 1056-1062.

599. Pajovic SB, Pejic S, Stojiljkovic V, Gavrilovic L., Dronjak S., Kanazir DT, Alterations in hippocampal antioxidant enzyme activities and sympathoadrenomedullary system of rats in response to different stress models, Physiological Research, 2006, 55:453-460.

600. Shelburne CP., Ryan JJ. The role of Th2 cytokines in mast cell homeostasis, Immunological review 2001, 179: 82-93.

601. Newsholme EA., Leech AR. Biochemistry for the Medical Sciences,2nd ed. John Willey, NewYork. Newsholme and Leech, 1988,29-32.

602. Wang JJ., Shieh MJ., Kuo SL., Lee CL., and Pan TM. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Applied Microbiology and Biotechnology 2006, 70: 247-253.

603. Wang, L., Zhang, H. L., Lu, R., Zhou, Y. J., Ma, R., Lv, J. Q., et al. The decapeptide CMS001 enhances swimming endurance in mice. Peptides 2008,29: 1176-1182

604. Wagenmakers AJ., Beckers EJ., Brouns F., Kuipers H. Soeters PB. Carbohydrate supplementation, glycogen depletion, and amino acid metabolism during exercise. American Journal of Physiology -Endocrinology and Metabolism 1991, 260: 883-890

605. Suh SH , Paik IY, Jacobs K. Regulation of blood glucose homeostasis during prolonged exercise. Molecules and Cells 2007; 23(3):272-279.

606. Jia JM. and Wu CF. Antifatigue activity of tissue culture extracts of saussurea involucrate pharmaceutical Biology 2008 ,46: 433^36.

607. Sahlin K. Metabolic factors in fatigue. Sports Medicine 1992,13: 99-107.

608. Holloszy JO., Kohrt M., Hansen PA. The regulation of carbohydrate and fat metabolism during and after exercise. Frontiers in Bioscience 1998 ,3:1011-1027.

609. Rennie MJ., Winder WW., Holloszy JO. A sparing effect of increased plasma fatty acids on muscle and liver glycogen content in the exercising rat. Biochemical Journal 1976; 156: 647-655.

610. Hickson RC, Rennie MJ., Conlee RK., Winder WW., Holloszy JO Effects of increased plasma fatty acids on glycogen utilization and endurance. Journal of Applied Physiology 1977,43: R829-R833.

611. Ivy JL., Costill DL., Fink WJ., Lower RW. Influence of caffeine and carbohydrate feedings on endurance performance. Medicine and Science in Sports and Exercise 1979,

11:6-11.

612. Walberg, JL., Greenwood, MRC, Stern, JS. Lipoprotein lipase activity and lipolysis after swim training in obese Zucker rats. American Journal of Physiology 1983,245: R706-R712.

613. Evans D A., Subramoniam A., Rajasekharan S., and Pushpangadan P. Effect of trichopus zeylanicus leaf extract on the energy metabolism in mice during exercise and at rest., Indian Journal of Pharmacology 2002,34: 32-37.

614. Koo HN., Lee JK., Hong SH., and Kim HM. Herbkines increases physical stamina in mice. Biological and Pharmaceutical Bulletin 2004,27(1): 117-119.

343

Bibliography

615.26. Feling E., Wahren J. Amino acids metabolism in exercising man. Journal of Clinical Investigation

1971,50:2703-2714.

616.27. Okamura, K., Matsubara, F., Yoshioka, N., Kikuchi, Y., Kohri H. Exercise-induced changes in branched-chain amino acid/aromatic amino acid ratio in the rat brain and plasma. Japanese Journal of Pharmacology 1987,45: 243-248

617. Kannur DM, Kulkarni AA., Paranjape MP. Navangul MV. Screening of antistress properties of herbal extracts and adaptogenic agents - A review. Pharmacognosy review 2008 Volume : 2 Issue : 3 95-101.

618. Dorren B. Physiological changes in rats exposed to cold/restraint stress Life science Vol23:issuie:23 1978,2307-2313.

619. Juvekar AR, Nachankar RS. Restraint stress induced changes and their modification by Spirulina platensis in albino rats: An experimental study. Acta Horticulturae (ISHS) 2005;680:49-55

620. Biswas NM, Sengupta R, Roychaudhuri G, Chattopadhyay A, Sarkar M. Prevention of adrenocortical hyperactivity by dietary casein in rats exposed to forced swimming stress. Indian Journal of Experimental Biology 2001;39:178-80.

621. Tache Y, Du Ruisseau P, Tache J, Selye H, Collu R. Shift in adenohypophyseal activity during chronic intermittent immobilization of rats. Neuroendocrinology 1976; 22:325-36,

622. Djhangiri B., Taubinand H I , Landsberg L Increased sympathetic activity in the pathogenesis of restraint ulcer in rat, The journal of pharmacology and experimental therapeutics 1973,Vol. 184, No 163-168.

623. Cumming JD., Haigh AL., Harries E H L.and Nutt M E. A study of gastric secretion abd blood flow in anaesthetized dog. Journal of Physiology. (London) 1963,168 :219-233.

624. Delaney JP. And Grime E. Experimentally induced variations in canine gastric blood flow and its distribution. American. Journal of. Physiology 1965,208:353-358.

625. Bullough WS. The control of mitotic activity in adult mammalian tissues. Biological. Review 1962, 37:307-326.

626. Bullough WS. and Laurence EB. Mitoticcontrol by internal secretion : The role of the chalone-adrenaline complex. Experimental. Cell Research 1964. 33:176-194.

627. Jian fu Zhang and , Zheng F. The role of Paraventricular nucleus of hypothalamus in stress ulcer formation in rats. Brain research 19997,761 203-209.

628. Nentwich S. , Sze'pfalusi K., Spurgin U. Antigenicity for Humans of Cow Milk Casein, Casein Hydrolysate and casein Hydrosylate fractions Acta Veterinaria BRNO 2004,73:291-298.

629. Marsh JT. and Rasmussen AF. Response of adrenals, thymus, spleen and leukocytes to shuttle box and confinement stress. Procedings of the Society for Experimental Biology and Medicine 1960, 104: 180-183.

630. Pederson BK HoffemanGoetz L.Exercise and the immune system regulation .integration and adaptation. Physiological Review 2000, 80:1055-81.

631. Mehrotraa S.,.Mishraa KP, Mauryab R., Srimale RC, Singh VK. Immunomodulation of ethanolic extract of Boerhvia diffusa roots. International Immunopharmacology 2002,2:987-996.]

632. Kapel M. .Paulsen T, Galbo H, Pederson BK. Effect of norepinephrine infusion on immune parameters Europoean Journal of Applied Physiology 1998,79: 93-98.

344

Bibliography

633.. Vernikos J., Dallman MF., Bonner C, Katzen A., Shinsako J. Pituitary adrenal function in rats chronically exposed to cold. Endocrinology 1982,110: 413-420,2.

634. Rai D., Bhatia, G., Sen T., Palit G. Comparative study of perturbations of peripheral markers in different stressors in rats. Canadian Journal of Physiology and Pharmacology, 2003a 81, 1139-1146.

635. Dadkar VN.,Ranadire NJ.JDhar HL. Evaluation of antistress (Adaptogenic ) activity of Withania somnifera.Indian Journal of clinical Biochemistry 1987,2:101 -108.

636. Chrousos GP, Gold PW. The concept of stress and stress system disorders. JAMA 1992; 267: 1244- 52.

637. Bijlani HL.,Sud S, Gandhi BM.,Tandon BN Relationship of examination stress to serum lipid profile, Indian Journal of Physiology and pharmacology 1985,30(l):22-30.

638. Glavin GB. Selective noradrenaline depletion markedly alters stress responses in rats Life Sciences, 198 Vol. 37,No-5 pp. 461-465.

639. Singh N, Mishra N, Srivastav AK, Dixit KS, Gupta GP Effect of Antistress plants on biochemical changes during stress reaction. Indian Journal of pharmacology, 1991,23:137-142.

640. Inoue TT ,Suchiya K, Koyama T Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in rat brain. Pharmacology Biochemistry and Behaviour. 1994, 49:911-920

641. Bhattacharya SK. Evaluation of adaptogenic activity of Trasina, an Ayurvedic herbal formulation. In: Mukherjee B, editor. Traditional medicine.New Delhi: Oxford and IBH Publishing; 1993. 320-6.

642. Maier, SF.; Seligman, MEP. Learned heplessness: Theory and evidence. Journal of Experimental Psychology. [Gen.] 1976,105: 3-46.

643. Murfia VS.; Molina VA. Antidepressants reduce inactivity during both inescapable shock administration and shuttle box testing. European. Journal of Pharmacology 1991,204:187-192.

644. Henn, FA. Animal models. In: Mann, J. J., eds. Models of depressive disorders. New York: Plenum; 1989:93-117.

645. Seligman ME P.; Beagley G. Learned helplessness in the rat. Journal of Comparative. Physiology and Psychology 1975, 88:534-541.

646. Greenberg L.; Edwards E.; Henn FA. Dexamethasone suppression test in helpless rats. Biological. Psychiatry 1989, 26:530-532.

647. Haracz JL.; Minor TR.; Zimmerman EG. Learned helplessness: An experimental model of the DST in rats. Biological. Psychiatry 1988, 23:388-396.

648. Henn FA.; Edwards E.; Spencer L.; Watanabe Y.; McEwen BS. Corticosterone response to restraint stress in rats bred for learned helplessness. Society for. Neuroscience. Abstr.1991,17:1557.

649. Geoffrey M, Tvede K, Anne T, Christensen V. and Schout JS. The Effect of Imipramine and Lithium on "Learned Helplessness" and Acetylcholinesterase in Rat Brain. Pharmacology Biochemistry & Behavior 1999, Vol. 38: 93-97.

650. Anisman H., DeCatanzaro D. and Remington G. Escape performance following exposure toinescapable shock: deficits in motor response maintenance, Journal of. Experimental. Psychology: Animal Behaviour Processes 1978,4 :197-218.

345

Bibliography

651. Karczmar AG., Scudder CL. and Richardson DL., Interdisciplinary approach to the study of behavior in related mice types. In S. Ehrenpreis and I. J. Kopin (Eds.), Chemical Approaches to Brain Function, Academic Press, New York, 1973.

652. Van der zee EA. and. Luiten PGM. Muscarinic acetylcholine receptors in the Hippocampus, neocortex and amygdala: a Review of immunocytochemical localizations relation to learning and memory JProgress in Neurobiology 1999,Vol. 58,. 409-471.

653. Borsini P., Bendotti C , Velkov V., Rech R. and Samanin, R. Immobility test: effects of 5hydroxytryptaminergicdrugs and role of catecholamines in the activity of some antidepressants. Journal of Pharmcy and. Pharmacology 1981., 33 : 33-37.

654. Leshner AI.; Segal M. Fornix transection blocks "learned helplessness" in rats. Behavioral and. Neural Biology 1979,26:497-501.

655. Petty F.; Sherman AD. Regional aspects of the prevention of learned helplessness by desipramine. Life Sciences 1980,26:1447-1452.

656. Divac I.; Dberg, RGE. The neostriatum. Oxford: Pergamon Press; 1979.

657. Corum CR. and Thurmond JB., Effects of acute exposure to stress on subsequent aggressionand locomotion performance, Psychosomatic. Medicines 1977, 39 : 436-443.

658. Glazer, H. I. and Weiss, J. M., Long-term and transitory interference effects, Journal of. experimental. Psychology: Animal Behaviour Processes 1976,2 :202-213.

659. Maier SF., Albin RW. and Testa TJ., Failure to learn to escape in rats previously exposed toinescapable shock depends on the nature of escape, response, Journal of. comparative. Physiology and Psychology 1973, 85 :581-592.

660. Overmier JB. and Seligman, MEP., Effects of inescapable shock on subsequent escape and avoidance learning, Journal of. comparative. Physiology and Psychology 1967, 63 :23-33.

661. Anisman, H., Time-dependent variations in aversily motivated behaviors: non-associative etfectsof cholinergic and catecholaminergic activity, Psychological Review, Vol 82(5), Sep 1975, 359-385.

662. Glazer HI., Weiss JM., Pohorecky LA. and Miller NE., Monoamines as mediators of avoidance-escape behavior, Psychosomatic. Medicines 1975., 37 :535-543.

663. Kushida CA. Sleep deprivation Basic science, Physiology and Behaviour, Volume 192:464-465.

664. Medeiros R. Neuroethologic differences in sleep deprivation induced by single and multiple platform methods. Brazillian Journal of Medical and Biological research May 1998, 31(5): 675-680.

665. (http://en. Wikepidia.org/wiki/sleep_deprivation)

666. Vgontzas AN, Tsigos C, Bixler EO, Stratakis CA, Zachman K.Kales A, Vela-Bueno A, Chrousos GP. Chronic insomnia and activity of the stress system: a preliminary study. Journal of Psychosomatic Research 1998;45:21-31.

667. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G,Vela-Bueno A, Kales A, Chrousos GP. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. Journal of Clinical Endocrinology and Metabolism 2001; 86:3787-94.

668. Jouvet M. Sleep and serotonin: an unfinished story. Neuro psychopharmacology 1999; 21:248-78.

669. Ursin R. Serotonin and sleep. Sleep Medicine Reviews 2002; 6: 57-69.

346

Bibliography

670. Cape EG, Jones BE. Differential modulation of high frequency gamma electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. Journal of Neuroscience 1998 ; 18:2653

671. Jacobs BL. Electrophysiological and behavioural effects of electrical stimulation of the raphe nucleus in cats. Physiology and Behaviour 1973; 11:489.

672. Chaouloff F, Berton O, Mormede P. Serotonin and stress. Neuropsychopharmacology 1999;21:28S-32S.

673. Jouvet, M. Mechanisms of the states of sleep: A neuropharmacological approach. In: Sleep and Altered States of Consciousness, Proceedings of the Association for Research in Nervous and Mental Disease 1967, 86-126

674. Hery F, Pujol JF, Lopez M, Maconand J and Glowinski J. Central 5-HT metabolism during paradoxical sleep deprivation. Brain Research 1970, 2 1 : 391-403.

675. Silva RH, Abilio VC, Takatsu AL, et al. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 2004; 46: 895- 903.

676. Youngblood BD, Zhou J, Smagin GN. Sleep deprivation by the flower pot technique and spatial reference memory. Physiology and Behavior 1997; 61:249- 56.

677. Kim EY, Mahmoud GS, Grover LM. REM sleep deprivation inhibitsLTP in vivo in area CA1 of rat hippocampus. Neuroscience Letter 2005; 388:163- 7.

678. Graves LA, Heller EA, Pack AI, et al. Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. Learning and Memory 2003; 10:168- 76.

679. Kim JJ.; Fanselow MS. Modality-specific retrograde amnesia of fear. Science 1992,256:675-677.

680. Nunes GP., Jr.; Tufik, S.; Nobrega, JN. Autoradiographic study of dopaminergic and cholinergic receptors after paradoxical sleepdeprivation. Sleep Research 1993,22:339.

681. Bartus, RT. Cholinergic drug effects on memory and cognition in animals. In: Poon, L, W., ed. Aging in the 1980s: Psychological issues. Washington, DC: American Psychological Association;1980,163-180.

682. .Kesner RP. Re-evaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiology of Aging 1988,9:609-616.

683. Skinner DM.; Overstreet DH.; Orbach, J. Reversal of the memory-disruptive effects of REM sleep deprivation by physostigmine. Behavioral Biology 1976, 18:189-198.

684. Troncone LRP.; Braz S.; Benedito MAC; Tufik S. REM sleep deprivation induces a decrease in norepinephrine-stimulated 3H-cyclic AMP accumulation in slices from rat brain. Pharmacology Biochemistry and Behavior 1986,25:223-225.

685. Tufik S.; Troncone L. R. P.; Braz S.; Silva-Filho A.; Neumann B. G. Does REM sleep deprivation induce subsensitivity of presynapticdopamine or postsynaptic acetylcholine receptors in the rat brain. European. Journal of Pharmacology 1987,140:215-219.

686. Hartmann E.; Stern WC. Desynchronized sleep deprivation:Learning deficit and its reversal by increased catecholamines. Physiology and Behaviour 1972, 8:585-587.

687. Stern WC; Morgane PJ. Theoretical view of REM sleep runction:Maintenance of catecholamine systems in the central nervous system. Behavioral Biology 1974,11:1 -32.

347

Bibliography

688. Decker MW.; McGaugh JL. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 1991,7:151-168.

689. Herman JP, Schafer KH, Sladek CD, et al. Chronic electroconvulsiveshock treatment elicits up-regulation of CRF andAVP mRNA in select populations of neuroendocrine neurons. Brain Research 1989;501:235-46.

690. Narendhirakannan RT, Subramanian S, Kandaswamy M.Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats. Clinical and Experimental Pharmacology and Physiology 2006, Dec 33(12):1150-7.

691. Lisanby SH., Electroconvulsive therapy for depression. New. England Journal of Medicine 2007, 357: 1939-1945.

692. Lisanby SH., Maddox JH., Prudic J., Devanand DP., Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Archieves of General Psychiatry 2000, 57: 581-590.

693. Pigot M., Andrade C , Loo C. Pharmacological attenuation of electroconvulsive therapy-induced cognitive deficits: theoretical backgroundand clinical findings. Journal of ECT'2008,24: 57-67.

694. MacPherson, R., Loo, C. Cognitive impairment following electroconvulsive therapy—does the choice of anesthetic agent make a difference? Journal of. ECT 200$, 24: 52-56.

695. Sackeim HA., Memory and ECT: frompolarization to reconciliation. Journal of ECT 2000,16: 87-96.

696. Nobler MS., Sackeim HA., Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. Journal of ECT'2008,24: 40-45.

697. Farlow MR., NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics 2004,59: 22-27.

698. Reid IC, Stewart CA. Seizures, memory and synaptic plasticity. Seizure 1997, 6: 351-359.

699. Brun VH., Ytterbo K., Morris RG., Moser MB., Moser EI. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated longterm potentiation. Journal ofNeuroscience 2001,21: 356-362.

700. Stewart C , Jeffery K., Reid I., LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuro Report 1994, 5: 1041-1044.

701. Stewart, C , Reid, I. Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Research 1993, 620: 139-141

702. Reid IC, Stewart, CA., Seizures, memory and synaptic plasticity. Seizure 1997, 6: 351-359.

703. Nagaraja N., Andrade C, Sudha S., Singh NM., Chandra JS.,Venkataraman BV. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berl.) 2007, 190: 73-80.

704. Home RL., Pettinati HM., Menken M., Sugerman AA., Varga E., Wilson GF. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia. Biological Psychiatry 1984,19: 13-27.

705. Chamberlin E., Tsai GE. A glutamatergic model of ECT-induced memory dysfunction. Harvard Review of Psychiatry 1998, 5: 307-317.

706. .Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of general psychiatry 2000, 57: 925-35.

348

Bibliography

707. Gordana Zupan, Kristina Pilipovic, Ana Hrelja, Sandra Peternel Oxidative stress parameters in different rat brain structures after electroconvulsive shock-induced seizures Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32: 771-777.

708. Poland JL.; Myers TO.; Witorsch RJ.; Brandt RB. Plasmacorticosterone and cardiac glycogen levels in rats after exercise. 1975 ,150:148-150.

709.. Negrao AB, Deuster PA, Gold PW, Singher A and Chrousos GP, Individual reactivity and physiology of the stress response, Biomedicine and pharmacotherapy 2000, 54 (3): 122 -28.

710. Paris JM., Lorens SA., Van de Kar LD., Urban JH.,Richardson Morton KD., Bethea, CL. A comparison of acute stress paradigms: hormonal responses and hypothalamic serotonin. Physiology and Behaviour, 1987, 39: 33-43.

702. Jefferys D. and Funder JW. Glucocorticoids, adrenal medullary opioidsand the retention of a behavioral response after stress, Endocrinology 1987, 12: 1006.

703. Jefferys DD. Irbyand CD and. Funder JW. Behavioural effect of adrenalectomy: reversal by glucocorticoids of [D-AIa 2-MetS]enkephalinamide, European Journal of Pharmacology 1983,. 92: 99

704. Bfiez M., and Volosin M., Corticosterone influences forced swim induced immobility, Pharmacology Biochemistry and Behavior 1994,49 (3): 729.

705. U.S. Army Research Institute of Environmental Medicine. Prevention and management of cold weather injuries. Technical Bulletin Medical 508.Washington, D.C.: Department of the Army, www.usariem.army.mil

706. Ferretti G, Ishii M, Moia C, Cerretelli P. Effects of temperature on me maximal instantaneous muscle power of humans. European Journal of Applied Physiology and Occupational Physiology. 1992; 64(2): 112-116.

707. Tache Y, and Selye H. Shift in adenohypophyseal activity duringchronic intermittent immobilization of rats, Neuroendocrinology 1976 ,22: 325 - 36.

708. Ganong, WF., Alpert LC. and Lee TC, New. England. Journal of. Medicines 1974,290: 1006.

709. Johnson LR., Ruhmann-Wennhold. A and Nelson D H., Annals ofNew.York Acadamy of Science 1972, 212: 307.

710. Gwynne JT., Mahaffee D., Brewer HB., Jr., and Ney RL. Proceedings of the National. Academy of Science 1976, USA73,4329.

711. Alfano J., Pedersen RC, Kramer RE. and Brownie A., Canadian Journal of Biochemistry and Cell Biology 1983., 1(7): 708

712. Johnson LR.; Ruhmann-Wennhold A.; Nelson DH. The in vivo effect of ACTH on utilization of reducing energy for pregnenolone synthesis by adrenal mitochondria. Annals of. New York Academy of Science 1972, 212: 307-318.

713. Giagnoni G.; Santagostino A.; Senini R.; Fumagalli P.; Cori E. Cold stress in the rat induces parallel changes in plasma and pituitary levels of endorphin and ACTH. Pharmacology Research Communication 1983, 15:15-18.

714. Papadopoulos NM., Bloor CM., Standefer JC. Effects of exercise and training on plasma lipids and lipoproteins in the rat. Journal of Applied physiology 1969,26:760-763.

715.Vallerand AL Jacobs I., Energy metabolism during cold exposure. International Journal of Sports Medicine Oct 13 1992 , Suppl l:S191-3.

349

Bibliography

716. Sapolsky RM., Krey LC, McEwen BS.,. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrine. Reviews 1986 ,7: 284-301

717. Finkelstein Y., Koffler B., Rabey JM.and Gilad GM., Dynamics of Cholinergic Synaptic Mechanisms in Rat Hippocampus After Stress. Brain Research 1985, 343 : 314-319

718. Sonia J., Lepage LM., Stress, memory, and the hippocampus: can't live with it, can't live without it. Behavioural Brain Research 2001,127 : 137-158.

350